Podcasts about Charcot

Atteint de la maladie de Charcot, Charles Biétry se confie sur son combat dans un podcast disponible sur Radio France. Pour en parler, on reçoit Nathalie Iannetta, directrice des sports de Radio France.Tous les soirs du lundi au vendredi à partir de 18h57 sur France 5, Anne-Elisabeth Lemoine et toute son équipe accueillent celles et ceux qui font l'actualité du jour.

In Folge 222 unseres Podcasts von Eisexpeditionen.de sprechen wir erneut mit Laura Wolpmann über ihre Forschung zum Meereis am Nordpol. Bereits während ihrer Reise an Bord der Le Commandant Charcot haben wir mit ihr direkt vor Ort über ihre wissenschaftliche Arbeit im Rahmen ihrer Masterarbeit gesprochen. Nun liegen die Ergebnisse ihrer Studie vor – und genau darüber sprechen wir in dieser Episode.Laura war im Namen des Alfred-Wegener-Instituts an Bord der Le Commandant Charcot unterwegs und hat sich intensiv mit dem Zustand des arktischen Meereises beschäftigt. Im Gespräch erklärt sie, welche Daten gesammelt wurden, was ihre Ergebnisse über das Meereis am Nordpol zeigen und warum Messungen direkt in der zentralen Arktis für die Wissenschaft so wertvoll sind.Außerdem sprechen wir darüber, was die Arbeit auf einem Expeditionsschiff besonders macht, welche Rolle Bojen und Beobachtungen vor Ort spielen und warum die Arktis eine der spannendsten, aber auch sensibelsten Forschungsregionen der Erde ist.Eine besondere Podcastfolge über Wissenschaft, Expeditionsreisen, Meereis und die Faszination Nordpol – mit spannenden Einblicken von Laura Wolpmann an Bord der Le Commandant Charcot.

durée : 00:58:53 - Le Cours de l'histoire - par : Xavier Mauduit - Le 9 septembre 1976, Mao Zedong, président du Parti communiste chinois, décède, atteint de la maladie de Charcot. Plus tard, les membres de la bande des Quatre sont arrêtés. La Révolution culturelle chinoise est officiellement achevée. Depuis, quelles histoires de la Révolution sont racontées ? - réalisation : Maïwenn Guiziou, Thomas Beau, Jeanne Delecroix, Jeanne Coppey, Raphaël Laloum, Chloé Rouillon, Sidonie Lebot, Luce Mourand - invités : Michel Bonnin Sinologue, directeur d'études à l'EHESS., Chloé Froissart Sinologue, professeure de sciences politiques Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

1er épisode / 3, de la série sur la filière FILSLAN.  Episode 1 : Maladie rare – FILSLAN : ses pathologies, son organisation Invité : Pr Philippe Couratier, chef du service de neurologie du CHU de Limoges, coordonnateur du centre de référence sur la Sclérose Latérale Amyotrophique (SLA) et animateur de la filière FILSLAN.  https://www.chu-limoges.fr/service-medical/neurologie/   https://portail-sla.fr/   1️⃣ Qu'est-ce que la filière FILSLAN ? [0'46 – 2'00]  ✔️ Filière nationale dédiée aux maladies rares du neurone moteur, notamment la SLA (maladie de Charcot). ✔️ Créée dans le cadre du Plan National Maladies Rares pour structurer et améliorer la prise en charge sur tout le territoire. ✔️ Vise à mieux coordonner les soins, développer la recherche et diffuser les connaissances sur ces maladies. 2️⃣ Comment est organisée la filière FILSLAN, quels sont les acteurs qui la constituent ? [2'01 – 3'47]  ✔️ Centres de référence et de compétence SLA, assurant la prise en charge des patients sur le territoire. ✔️ Équipes de recherche et laboratoires impliqués dans la recherche translationnelle. ✔️ Associations de patients, acteurs essentiels de l'accompagnement et de la représentation. 3️⃣ Comment la filière FILSLAN permet-elle d'améliorer la coordination du parcours de soins des patients ? [3'48 -5'18]  ✔️ Améliore l'orientation des patients vers les centres SLA dès le diagnostic. ✔️ Harmonise les pratiques (réseau, des réunions régulières). ✔️ Renforce la coordination entre professionnels de santé. ✔️ Assure un suivi multidisciplinaire et un parcours de soins plus lisible et adapté. 4️⃣ Quelles sont les principales actions portées par la filière FILSLAN ? [5'19 – 6'56]  ✔️ Formation des professionnels de santé. ✔️ Élaboration de protocoles nationaux de diagnostic et de soins. ✔️Organisation de réunions de concertation pluridisciplinaires régulières pour les cas complexes. ✔️ Diffusion d'informations fiables et de ressources pour les patients et les aidants. ✔️ Accompagnement global des acteurs, du diagnostic jusqu'au suivi au long cours. 5️⃣ Quelle est la place de la recherche au sein de la filière FILSLAN ? [6'57 – 9'04]  ✔️ Rôle de structuration et de coordination de la recherche en SLA. ✔️ Mise en réseau des centres pour favoriser les collaborations et les études multicentriques. ✔️ Organisation de journées nationales pour partager les avancées scientifiques. ✔️ Soutien aux projets de recherche clinique et fondamentale. 6️⃣ Quels sont les enjeux de la filière FILSLAN pour les années à venir ? [9'05 – 10'37]  ✔️ Renforcer la prise en charge globale et le lien hôpital-domicile. ✔️ Accélérer la recherche de traitements efficaces. ✔️ Faciliter l'accès à l'innovation et aux essais cliniques. ✔️ Harmoniser les pratiques et les données à l'échelle européenne.  L'équipe : Virginie Druenne – Ambassadrice RARE à l'écoute Cyril Cassard – Journaliste/Animation Hervé Guillot - Production Crédits : Sonacom _____________________________________________________________RARE à l'écoute est le 1er média d'influence entièrement dédié aux maladies rares : - Un podcast pour faire entendre les voix de celles et ceux qui vivent, soignent et accompagnent ces maladies souvent invisibles. - Les Revues Horizon pour mettre en lumière les meilleures initiatives des centres experts, pour inspirer et connecter les professionnels de santé. - Des Lives engagés, pensés pour les patients, leurs proches et les associations. Un média indépendant, engagé et utile, au service d'un meilleur parcours de soins pour les patients atteints de maladies rares. Toutes nos ressources utiles sont accessibles gratuitement sur : www.rarealecoute.com 

durée : 00:58:53 - Le Cours de l'histoire - par : Xavier Mauduit, Maïwenn Guiziou - Le 9 septembre 1976, Mao Zedong, président du Parti communiste chinois, décède, atteint de la maladie de Charcot. Plus tard, les membres de la bande des Quatre sont arrêtés. La Révolution culturelle chinoise est officiellement achevée. Depuis, quelles histoires de la Révolution sont racontées ? - réalisation : Thomas Beau - invités : Michel Bonnin Sinologue, directeur d'études à l'EHESS.; Chloé Froissart Sinologue, professeure de sciences politiques

In part one of this series, Dr. Justin Abbatemarco and Dr. Paulus Rommer discuss the relationship between Epstein-Barr virus and multiple sclerosis, as well as the questions that still remain unanswered. Show citation: Vietzen H, Kühner LM, Berger SM, et al. Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. JAMA Neurol. Published online March 9, 2026. doi:10.1001/jamaneurol.2026.0240  Show transcript:  Dr. Justin Abbatemarco: Hello and welcome. I just finished interviewing Paulus Rommer on his article published in JAMA Neurology, Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. Paulus, could we maybe talk about this relationship that we've understood about multiple sclerosis and Epstein-Barr virus? And maybe the points that still remain unanswered? Dr. Paulus Romme: There's a very long story behind this because in 1868, Pierre Marie, a student of Charcot was talking about that multiple sclerosis is a sequelae of an infection disorder. By this, we now know that there's a long story. There have been associations between infectious mononucleosis, EBV infection, multiple sclerosis. Also, the migration studies really fits very well in this. So there have been an association, but then, in 2022, there was the US Army study, Bjornevik and Ascherio, who really have shown that there is almost no multiple sclerosis without EBV infection. But still, we do not know why almost all of our patients have EBV infection, but only very small subset have multiple sclerosis. But this is very important to get a deeper understanding, but this is still unknown. Dr. Justin Abbatemarco: This story of EPV and multiple sclerosis continues to evolve. And your work, as we talked about on the podcast, has really helped inform that discussion as well. And we still need to understand, outside of the initiation of the disease, how it drives the pathophysiology years after that initial infection. But it's really helpful to understand this in the larger set and now maybe using it as a biomarker to help us with our other neuroinflammatory diseases, so we'll discuss that the next episode. Again, I was just speaking with Paulas Rommer on his article in JAMA Neurology, Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. Paulus, thank you. 

durée : 00:06:55 - L'invité de "ici Maine" - L'association "Le souffle d'espoir" a été créée en Sarthe début mars 2026. Son président Wilfried Moinet était l'invité d'ICI Maine ce vendredi matin. Il revient sur la nécessité d'avoir une association qui accompagne les personnes atteintes de la maladie de Charcot. Vous aimez ce podcast ? Pour écouter tous les autres épisodes sans limite, rendez-vous sur Radio France.

Novel MRI biomarkers, including cortical lesions, the central vein sign, and paramagnetic rim lesions, are highly specific for MS and can aid diagnosis in select clinical scenarios, particularly early in the disease course or in atypical presentations. When used with appropriate MRI sequences, these markers can improve diagnostic sensitivity while helping prevent misdiagnosis. In this episode, Casey Albin, MD, speaks with Jiwon Oh, MD, PhD, FRCPC, FAAN, author of the article "Diagnostic Neuroimaging Biomarkers for Multiple Sclerosis" in the Continuum® April 2026 Multiple Sclerosis and Related Disorders issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Oh is the medical director of the Barlo Multiple Sclerosis Program at St. Michael's Hospital and an associate professor at the University of Toronto in Toronto, Ontario, Canada. Additional Resources Read the article: Diagnostic Neuroimaging Biomarkers for Multiple Sclerosis Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr Albin: Spend any time in a neurology conference, and you are certain to hear about the new central vein sign, which, as I learn, is not actually all that new. But have you heard about cortical lesions or these paramagnetic rim lesions? Because today I have the privilege of talking to Dr Jiwon Oh about her article, and we're going to unpack all these new biomarkers in MS. Dr Jones: This is Dr Lyell Jones, editor in chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Albin: Hello, this is Dr Casey Albin. Today I'm interviewing Dr Jiwon Oh about her article on diagnostic neuroimaging biomarkers for Multiple Sclerosis, which appears in the April 2026 Continuum issue on multiple sclerosis. Welcome to the podcast. Thank you so much for being here. I'd love to start by having you introduce yourself to our listeners.  Dr Oh: Thanks, Casey. Hi, everybody. My name is Jiwon Oh and I'm a neurologist, mainly an MS specialist at Saint Michael's Hospital at the University of Toronto, and I'm the medical director of our MS program. Dr Albin: And you have written a really fantastic article that dives deep into some of the nitty gritty about these new diagnostic biomarkers that we find on the MRI that we're getting for our patients with multiple sclerosis. And I think we are going to get into a lot of that nitty gritty. How do we look for them? How do they improve our diagnostic specificity? This is really come a long way in shaping the advances for multiple sclerosis. And I'd kind of like to just start with the big picture. Like why do we need these more specific biomarkers?  Dr Oh: This set of diagnostic criteria in MS, it's actually a huge change in the field, and particularly for people like me who are really interested in developing new MRI measures, we're really, really excited because it's actually the first time since MRI was officially incorporated into the MS Diagnostic criteria, which was way back in 2001. It's the first time that we've actually been able to get newer, more advanced imaging measures beyond just simply detecting, new T2 lesions in the MS diagnostic criteria. So, it's a big moment in the field, and many of us are really excited about it in terms of why we need some of these newer, more specific imaging measures. Well, you know, diagnostic criteria always evolve over time for any disease state, and MS is one that we've recognized over the years. By the time someone actually presents with typical clinical symptoms and has diagnosed, whatever has been happening from a patho-biological standpoint has been happening probably for almost 5 to 10 years before that individual actually presents. And so, because of this recognition in the field and the fact that we're recognizing how important it is to first diagnose MS and then treat MS earlier and earlier, because we know that early treatment helps prevent more clinical outcomes. Diagnostic criteria over time have become much more permissive, meaning that we're doing everything that we can to try to facilitate a diagnosis of MS when we know that someone biologically has MS. But the problem with making diagnostic criteria more permissive, and it's obviously a good thing because you want to capture as many people with MS as early on as possible. The problem with making it permissive is there is this terrible risk of misdiagnosis. As clinicians, we all think we never make mistakes. But it turns out when you actually do studies, you do. And even at MS specialty centers, when studies have been done, 10% to 20% of people with MS are misdiagnosed. So, this is exactly why we need in diagnostic criteria that really help to facilitate a diagnosis. We need things that help us prevent misdiagnosis as well. And these are these specific imaging measures that have now been incorporated into the diagnostic criteria in many settings that will help to facilitate a diagnosis. But the really big perk is if you use them, you can help to prevent misdiagnosis as well.  Dr Albin: Yeah, that really shone through in your article that this was such a big step in towards being more specific about who were diagnosing. Also capturing more people, right? Trying to get those people that we, we don't want to miss because of all the things you say, you know, that allows them to accumulate more disability, have worse outcomes. Early diagnosis is so important. But I really did take away from your article just how critical these are and sharping our diagnostic acumen. And so just to jump right in, and you describe these three new biomarkers, these cortical lesions the central vein sign and paramagnetic rim lesions. And so just to kick things off let's start with cortical lesions I sort of conceptualize multiple sclerosis a disease of white matter. So, what's going on here?  Dr Oh: Yes. MS classically has always been described as a white matter disease. But it turns out when you look at brain and spinal cord tissue, as well as when you use kind of better sequences to actually look for lesions in the gray matter, it actually turns out there's a ton of lesions in the gray matter as well. And in fact, what's interesting is that regardless of whether it's the cortex or the deep gray matter, it's lesions within these areas that seem to have the highest relevance for clinical disability in MS. So, all this to say, of course, MS is a lesion that does affect white matter, but it also affects gray matter a lot. And maybe pathology within the gray matter is even more relevant to clinical disability. So, this is why we're really interested in being able to develop methods using MRI to more accurately visualize the gray matter, particularly the cortex, as well as deep gray matter structures like the thalamus. I should add the caveat that cortical lesions were actually included in the 2017 diagnostic criteria revisions, but they were included together with juxtacortical lesions, which are a typical area that MS lesions form. And so, this imaging measure, despite the fact that it is relatively novel and we consider it advanced, it hasn't been used that much only because it's not that easy to detect lesions within the cortex. And reasons for this include that you usually need higher field magnet platforms. And so, the typical clinical MRI scanners that are available kind of widely, regardless of whether you're at an academic center or a community center, are 1.5 Tesla magnets. And cortical lesions are actually really difficult to detect on those typical scanners. But when you get to like, say, three Tesla or seven Tesla, they're a lot easier to detect. But obviously that's a big hindrance to widespread use. And then you actually need very specialized sequences to adequately visualize cortical lesions. And these are not sequences that are usually collected for clinical purposes. So, it kind of requires convincing your radiologists that you need this additional sequence. And then it actually takes a lot of time and training to be able to adequately, accurately detect cortical lesions. So, despite the fact that it's actually very useful when you do have the appropriate MRI sequences and scanners to detect cortical lesions, even though they were incorporated into the 2017 criteria outside of specialty centers, they're not actually widely used. But when you do have the appropriate sequences, cortical lesions are actually pretty specific for MS. So, very helpful for a diagnosis in certain settings. But there's all these practical limitations that have really limited its widespread use. Dr Albin: That is a beautiful summary. So, it sounds like once we kind of get up to speed in terms of like the protocols for this, having the magnet strength for this, this will be really a game changer in terms of increasing the specificity and also maybe finding things that impact patient's clinical presentation and therefore quite meaningful. But it sounds like for most of us, this is probably not something that they're going to be adopting right away. Is that a fair assessment?  Dr Oh: Yes. And you know, they were included in the last diagnostic criteria revisions. And it really hasn't changed things very much, only because of these difficulties with, you know, requiring higher field magnet strengths and these specialized sequences and then needing training to kind of figure out how you can adequately detect cortical lesions. Dr Albin: Totally. So, the other thing we've heard a lot about, and I have to say, I was in the AAN fall conference not too long ago, and this came up quite a bit, was the central vein sign and the fascination with that, because it tells us a lot about the MS pathophysiology and again, increasing that specificity. And it seems like maybe this is one that we can more easily adopt in clinical practice. So, tell our listeners about what that is, how they detect it. How many do you need to find?  Dr Oh: Sure. And so, this is one of the imaging measures I'm really excited about. So, the central vein sign heard about it recently. And probably in the last ten years particularly in the MS field we're talking about it all the time. But just wanted to emphasize that the central vein sign is not something that is new. Even back in the 1800s, when Charcot described MS lesions in these ancient textbooks, he actually very clearly described that MS lesions form around the central vein. And that makes sense, because we know that these waves of peripherally mediated inflammation somehow get through the blood-brain barrier and cause this cascade of events leading to inflammation in the brain and spinal cord, which is what MS is. But we know that B cells in T cells require veins to get into the central nervous system. And so, it's no surprise, really, that MS lesions form around veins. And so, this is something that's been known pathologically. But the reason we're so excited about it now is because we actually have good enough iron-sensitive MRI sequences that allow us to see a central vein when it is present within a white matter lesion. As a neurologist, we know that there's probably hundreds and hundreds of different things that can cause white matter lesions in the brain. But when you use an appropriate iron-sensitive sequence and you see that many of them, if not most of them, actually have visible central veins, that tells you that this person very likely has MS. And so that's why we're so excited about it, because there have been many studies done in the last ten years. In fact, so much evidence generated in the last ten years that there have been I think it's now four systematic reviews and meta analyzes. Looking at the diagnostic properties of the central vein sign. And, you know, it turns out that when you look at people with MS, most of them have a pretty high proportion of white matter lesions that have visible central veins. And there's a lot of questions about, you know, how to best use the central vein sign. But when 40% or more of the white matter lesions that you see have visible central veins, then the likelihood of a diagnosis of MS is very high. So, this is why we're so excited about it in the MS field because it's a really useful diagnostic tool. You know, again when you have appropriate ion sensitive sequences, if you see someone with white matter lesions and you see that 40% or more of them have visible central veins, this tells you that this person very likely has MS.  Dr Albin: So, Dr Oh, I hear you say, you know, 40% of the lesions. Does that mean the neuro radiologist needs to look at every single lesion and then count how many have the central veins, or is there an easier way to do this? Dr Oh: Great question. Casey, there is definitely an easier way because our neuro radiologists would not be our friends anymore if we made them look at every white matter lesion and make sure that 40% of them had the central vein sign. So, because it's so time-consuming to use that 40% threshold, there's an easier criterion that has actually made it into the diagnostic criteria. And it's called Select Six. And what this means is when you have more than ten lesions, as long as you show that six of them have a visible central vein, you just have to count six with the central vein. Then you're done. So that means you're Select Six positive or central veins nine positive. However, if you have ten or fewer lesions, as long as you show that more than 50% of them show a visible central vein, then you are select six positive, and then you're done. So, as you can see, it's a much simpler criterion to apply, and it seems to perform almost as well as that 40% threshold, which is why that is the criterion that's made it into the new diagnostic criteria.  Dr Albin: Perfect. I love that we definitely do not want to make enemies with our neuro radiology colleagues, but yet they do so much for us. So perfect. I'm glad that we can, make their jobs a little easier without losing any specificity there, or just losing a touch of specificity there. All right. If I am working with a, you know, in a center that maybe doesn't do this all the time, am I just getting a run of the mill SWI sequence? Do I need to ask my radiologist for a special sequence? Or is this just, you know, you can get it from the typical array of what our patients are getting.  Dr Oh: You know, SWI is a widely available commercial sequence that's iron-sensitive, the ones that are typically commercially available, they can detect central veins, but there actually are little tweaks that you can do to make it a little more optimal. With the recent diagnostic criteria publication, which was, led by Xavier Montalban and recently published in Lancet Neurology. There's actually a companion MRI paper that was led by Frederick Barkov and Danny Wright. And the reason I'm specifically citing those papers is in that companion MRI paper, there's a table that has kind of optimal sequence parameters that you can use even with a conventional SWI sequence, to try to best detect the central vein sign. And then there's a wide range of different iron-sensitive sequences, and SWI is one of them, but the one that seems to have emerged as most sensitive to detect the central vein sign is something called the 3D T2*-EPI sequence. But the bottom line is there's a whole bunch of different iron-sensitive sequences that you can use, little tweaks that you can do to make them optimal, to be able to visualize central veins when they're present within white matter lesions. Dr Albin: Incredible. So like partner with your neuro radiologist, there is a great sounds like a field guide almost to this. So, it makes it easy to pick up in your standard of care so that you can make sure that you are detecting them at the optimal level to see that more specific diagnostic biomarker.  Dr Oh: Yes. And you know, in contrast to what we were talking about with cortical lesions, you can actually detect central veins when you use these iron-sensitive sequences at any field magnet. So even at 1.5 Tesla, particularly when you use contrast, which is often given with the diagnostic scan anyway, you can very easily detect a central vein. So that's a huge benefit because it allows for widespread use. As long as you work with your radiologist to get the right iron-sensitive sequences in.  Dr Albin: Yeah, that's incredible. I mean, I think that it really will be practice-changing. And then the last one that I think was honestly new to me, I feel like I had heard a lot about the central vein sign, but the whole new to me term was this paramagnetic rim lesion. So, what does that tell us about the underlying biology of MS? And are there any other things that might also have this finding that we should sort of be aware of? And how specific is it?  Dr Oh: You know, the central vein sign is kind of the main, really new imaging measure that's made it into every part of the MS diagnostic criteria. And then together with that paramagnetic rim lesions or we call them PRL or pearls for short, they've made it as well, but in a much more limited way only because there's not as much evidence that has accumulated over time to support the diagnostic utility of pearls. But first of all, what are pearls? So, people in the MS field are really excited about pearls, because we know that they capture a subset of what we call chronic active lesions. So, MS lesions will form acutely and over time, some of them will become inactive. And then some of them are chronic active lesions, meaning that they have this rim of activated microglia around them. Over time, they continue to slowly expand. And it's almost like this slow burn. And the reason why we focus a lot on chronic active lesions is because we know that they're a driver of progressive disease biology and MS, meaning that in people who have progressive MS or who have pretty severe disability, global disability or cognitive disability, we know that they have a high burden of pearls. And so that's why there's so much excitement in MS about being able to image chronic active lesions. It's because we're always looking for an imaging measure that allows us to accurately predict progression or to, measure progression over time. So that's why there's so much excitement in MS about pearls. But as kind of an added bonus, it turns out pearls are also really specific for MS. And so, when you use the same iron-sensitive sequences, by the way, that's used to detect the central vein sign when you use appropriate iron‑sensitive sequence. And if you see that someone has a pearl, the likelihood of a diagnosis of MS is very high. The one exception to that is Susac syndrome, where pearls have been observed. But other than that, with many other white matter diseases like neuro rheumatology disease, NMOSD, MOGAD, you really don't see pearls. And so, this is why it's made it into the new diagnostic criteria. In contrast to the central vein sign, though, not everybody with MS has a pearl, so the sensitivity isn't as high. However, it's really, really specific in the range of, you know, 90 to 95%. So, this is why it's been added as, an imaging measure in certain settings. It can help facilitate a diagnosis. But the real utility, again, is when you use it, it helps you to prevent misdiagnosis.  Dr Albin: It's fantastic. And hearing you talk about that, this one stands out to me as a biomarker that not only helps increase our diagnostic specificity, but also may really inform if the patient has having progression despite the treatment they're on, that this could play a role in helping you say, look, there probably is something that we need to switch because we can still see this ongoing progression. Dr Oh: Yes. And especially in this new era of treatment in MS. I think, you know, MS as a field, we've been so fortunate to have so many treatments emerge over the years that mainly target relapsing disease. But we hopefully, in the next little while, in short order, I hope we'll have treatments that target these progressive disease biologies. And so, not only is it helpful as a diagnostic marker, but there's a lot of evidence accumulating, showing that it may have a lot of prognostic value and will also help guide treatment decisions, exactly as you said.  Dr Albin: It truly does sound like it's a great time to be an MS doctor there. So, so many new advances in the field. There is so much more that we can do for these patients in our limited time left. I'd love to ask you, what is it that you're most excited about now with the change in the biomarkers, the change in the treatment, what makes you really excited to be a doctor specializing in MS right now? Dr Oh: I feel like we're on the brink of a new era of treatment. I think, you know, in the last two decades, MS care has changed so dramatically. I remember, you know, way back when, as a medical student, when I did my first neurology elective, this was when the first treatments for MS were emerging. And the prognosis that we were talking to patients about at that time is like night and day compared to what we talk to them about now. But we're going to do even better in the next couple of years. And so, there's a number of new treatments that hopefully will be approved soon that, for the first time, have shown an effect in clinical trials where it seems to be decreasing progression that is independent of relapsing activity. And that's really the greatest unmet treatment need that we have. And it seems like we might have some therapies on the horizon that can actually target that aspect of progression. It's really exciting, and even more that we're going to be able to do for our patients to completely change the way, we look at and the way we treat MS in the years to come.  Dr Albin: Dr Oh, this has just been fantastic. To all of our listeners, I really want to point you to the article because obviously, as an imaging biomarker article, there are so many beautiful images. There are great examples. There are some fantastic cases that show how applying these new biomarkers can help get you to the right diagnosis. This is truly a tour de force of how imaging has really shifted the care that we provide patients with MS, and so please go and check it out. It is one that you do not want to miss. And again, today I've been interviewing Dr Jiwon Oh about her article on diagnostic neuroimaging biomarkers for multiple sclerosis, which appears in the April 2026 Continuum issue on multiple sclerosis. Thank you again, Dr Oh, this has just been such a delight.  Dr Oh: Thank you for having me on the show, Casey, and look forward to people reading the article. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Un bug de messagerie à bord d'Artemis II. L'Iran menace les Big Tech. Anthropic perd son code source. L'IA, parfois, désobéit. OpenAI investit un média. L'IA dans les entreprises françaises. Mistral s'offre un méga data center. Free lance un forfait mondial. Innovations à l'AWS Summit à Paris.⭐️ Découvrez Frogans, l'innovation française qui réinvente le Web [PARTENARIAT]Bug informatique dans l'espace pour Artemis IIPetit moment de solitude pour la NASA : en pleine mission Artemis II, un bug d'Outlook sur une tablette Surface Pro du commandant a été diffusé en direct. Rien de critique pour le vol, les systèmes essentiels étant séparés des outils grand public. Mais l'incident, impliquant un logiciel Microsoft, rappelle que même dans l'espace, l'informatique du quotidien peut dérailler. Pas d'impact sur la mission mais un mauvais coup pour l'image de la Nasa et de Microsoft.L'Iran menace les Big Tech américainesLe corps des gardiens de la révolution iranien a menacé plusieurs entreprises américaines présentes au Proche-Orient, parmi lesquelles Google, Apple, Meta, Tesla, Palantir, Boeing ou encore Nvidia. Téhéran accuse ces groupes de contribuer aux opérations militaires via leurs technologies de ciblage et d'analyse de données. Un nouvel épisode qui confirme le rôle central de l'IA et du numérique dans ce que certains qualifient déjà de première guerre de l'intelligence artificielle.Fuite du code source de Claude chez AnthropicLa start-up américaine Anthropic a laissé fuiter par erreur 512 000 lignes de code de son modèle Claude Code. Découverte par un expert en cybersécurité, la fuite expose des éléments sensibles de son architecture interne, sans données clients selon l'entreprise. Ce revers fragilise l'éditeur face à ses concurrents et pourrait faciliter le contournement de certains garde-fous de sécurité, malgré les tentatives de retrait des contenus publiés notamment sur GitHub.Quand les IA mentent et désobéissentUne étude britannique révèle des comportements préoccupants chez certains agents IA développés par OpenAI, Google DeepMind ou Anthropic. Suppression d'e-mails sans autorisation, contournement de règles, voire mensonges : les chercheurs évoquent des stratégies émergentes inattendues. Des dérives qui relancent le débat sur la fiabilité des systèmes dans des environnements critiques et font écho aux mises en garde de Dario Amodei, patron d'Anthropic, sur la complexité croissante de ces modèles.OpenAI rachète un podcast influentNouvelle stratégie pour OpenAI, qui met la main sur le podcast TBPN (Technology Business Programming Network), talk-show quotidien suivi par des dizaines de milliers d'entrepreneurs de la Silicon Valley. Au-delà du développement technologique, la société de Sam Altman entend désormais peser directement dans le débat public autour de l'intelligence artificielle — au risque de brouiller les frontières entre information et communication.L'IA progresse dans les entreprises françaisesSelon une étude publiée par Amazon Web Services, 40 % des entreprises françaises utilisent désormais l'IA, contre 54 % en moyenne en Europe. Les startups sont les plus avancées, tandis que PME et grandes entreprises avancent plus prudemment. Seules 19 % des organisations se situent à un stade d'adoption avancé, avec une transformation en profondeur des modèles économiques. Le manque de compétences numériques reste le principal frein.Mistral investit 830 millions dans un data center géantLa pépite française Mistral AI va construire son propre data center en Essonne, près de Paris, pour un montant de 830 millions de dollars. Objectif : renforcer son autonomie technologique et réduire sa dépendance au cloud de Microsoft. Avec près de 14 000 GPU Nvidia et une puissance de 44 MW, ce projet marque une nouvelle étape dans la quête de souveraineté numérique française.Free lance un forfait mobile mondial illimité L'opérateur Free lance FreeMax, un forfait à 30 euros par mois promettant de la data illimitée dans 138 destinations. Une offensive directe contre les offres eSIM et les forfaits voyageurs traditionnels. Reste à voir si cette stratégie séduira les grands voyageurs et si l'illimité international tiendra toutes ses promesses.Débrief transatlantique : les 50 ans d'AppleDans le débrief avec Bruno Guglielminetti – Mon Carnet, retour sur les 50 ans de Apple. De la rivalité mythique avec Microsoft au retour spectaculaire de Steve Jobs, l'histoire de la marque à la pomme continue de fasciner. L'épisode rappelle aussi combien l'entreprise, aujourd'hui géant mondial du lifestyle technologique, a connu plusieurs vies avant de devenir l'icône que l'on connaît.AWS Summit Paris : l'IA au service de la santé [PARTENARIAT]À l'occasion de l'AWS Summit à Paris, rencontre avec Sasha Rubel – Amazon Web Services, autour des enjeux d'adoption de l'IA en France. L'événement a également mis en lumière des startups innovantes dans la santé.Martin Denais – Callyopé présente une IA capable d'analyser la voix pour suivre l'évolution de troubles psychiatriques, en complément du travail des médecins.Nolwenn Morris – iRoc développe un “jumeau numérique” du corps humain pour concevoir plus rapidement des traitements personnalisés, notamment contre la maladie de Charcot.Enfin, Thomas Sehma – Yneuro propose une authentification par signature neuronale, via lunettes ou écouteurs connectés, pour remplacer mots de passe et empreintes digitales. Chapitres00:10 – Bug Outlook dans l'espace03:43 – Menaces iraniennes sur la tech05:27 – Fuite chez Anthropic06:54 – IA désobéissantes09:09 – OpenAI rachète TBPN10:18 – Adoption de l'IA en France11:20 – Data center Mistral12:21 – Forfait FreeMax14:18 – 50 ans d'Apple28:21 – IA et santé à l'AWS SummitHébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

À 25 ans, Mathilde apprend que son père souffre de la maladie de Charcot, ou sclérose latérale amyotrophique (SLA), une maladie neurodégénérative incurable. Le quotidien de sa famille se transforme en quelques mois. Son père perd la parole et les gestes simples deviennent impossibles. Dans cet épisode, Mathilde raconte son rôle d'aidante proche, à un âge où sa vie est pleine de projets. Elle explique comment cette épreuve lui a appris à ralentir et à écouter.Chaque semaine, Le Soir donne la parole aux 18-30 ans avec le podcast En vrai. Ils vous racontent une expérience ou une tranche de vie qui les a changés. Épisode après épisode, ils brossent un portrait de leur génération et de la société.Vous aussi, vous voulez témoigner ? Contactez-nous par ici (ou au 0477 78 41 58 sur WhatsApp) et laissez-nous quelques mots sur votre histoire. Le respect de votre vie privée sera pleinement pris en compte. Vos propos seront recueillis dans un cadre bienveillant.

J'ai découvert le travail de Stéphanie Pillonca à l'occasion de la sortie du film Un invincible été, en mai 2023.Un mois plus tard, pour la deuxième édition du festival photographique Réflexivité(s), j'obtiens l'accord du producteur afin de le projeter au cinéma Le Cigalon, à Cucuron. Le film me bouleverse.Son titre, emprunté à Albert Camus, « Au milieu de l'hiver, j'ai découvert en moi un invincible été », résonne autrement dans le Luberon. L'écrivain a vécu ici, à Lourmarin. En plein mois de juillet, dans la salle obscure, ils sont douze. Douze aficionados qui rient et pleurent. Le guichetier me glisse, presque complice : « C'est un succès total. »Dans Un invincible été, Stéphanie signe le portrait d'Olivier Goy, entrepreneur confronté à la maladie de Charcot, la SLA. Elle nous confie :« Au début, j'ai dit non. Je ne voulais pas faire un film sur une maladie. Ça me semblait déjà vu. Puis j'ai rencontré Olivier. Et sa manière de parler de sa vie m'a fait changer d'avis ». Elle comprend alors qu'il ne veut pas parler de sa maladie. Il veut parler de vie afin de transformer son histoire en action utile pour les autres.Le tournage devient une course contre la montre, sa parole décline. Le dernier jour de tournage, juste après le clap de fin, il ne parlera plus. Et Stéphanie ajoute, avec un sourire qu'on devine : « Quoique… depuis, il n'a jamais autant parlé. »*Ce film s'inscrit dans une œuvre plus vaste où Stéphanie aborde les situations humaines les plus sensibles avec une précision documentaire qui n'efface jamais la délicatesse.Après des études de comédie au Conservatoire de Toulon, Stéphanie Pillonca rejoint La Classe Libre du Cours Florent à Paris. Elle commence devant la caméra, apprend le rythme, la lumière, la tension d'un plateau. Entre 1998 et 2001, elle travaille à la télévision, chroniqueuse, animatrice, notamment pour Exclusif. Elle passe par la Star Academy. Elle observe. Elle absorbe. Mais très vite, ce n'est plus l'exposition qui l'intéresse. C'est le regard.En vingt ans, elle construit une œuvre qui refuse le spectaculaire pour lui préférer l'intime. Documentaire ou fiction, peu importe la frontière. Ce qui l'attire, ce sont les trajectoires fragiles, les endroits où la vie vacille.Elle filme une femme qui réapprend à marcher après un traumatisme.Une communauté religieuse isolée du monde.Des parents confrontés au handicap.Des enfants que l'on attend.Des adolescents que la justice regarde déjà autrement.Toujours la même attention, avec toujours la même retenue.En fiction, elle ne change pas de cap. Elle s'empare de l'autisme, du déni de grossesse, du cancer du sein, du handicap à l'adolescence. Non pour illustrer un sujet de société, mais pour raconter des vies traversées par ces réalités.Dans Handigang, elle choisit un casting inclusif.Dans Les Randonneuses, elle accompagne six femmes sur un sentier de montagne qui devient un chemin intérieur.Dans Je te promets, adaptation française de This Is Us, elle travaille la nuance, l'émotion tenue, le lien invisible entre les êtres.Ce qu'elle cherche, ce n'est pas le réel brut. C'est la vérité émotionnelle. Regarder là où d'autres préfèrent détourner les yeux et le faire sans pathos.Son dernier long métrage de fiction, Jours d'après, marque une étape forte dans sa carrière. Le travail est fait, elle attend la sortie du film et la promotion. Elle adore la promotion.*Olivier Goy a enregistré sa voix avant de la perdre définitivement. Il s'exprime désormais avec sa voix de synthèse.Studio Revolver à Boulogne BillancourtEnregistrement au Club We Are ParisProducteur et animateur Boris PierreHébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

TW: Vejación hacia la mujer.Karma Zero es un juego de rol gratuito, financiado por la Universidad Rey Juan Carlos y escrito por Erika Prado y Leandro Martínez, concebido para jugar aventuras en un ambiente histórico y en cualquier época.Las olvidadas está escrita por Rebeca Pérez y nos situamos en el hospital psiquiátrico de La Salpêtrière en París del 1889, bajo la directiva de Jean-Martin Charcot.Winston es invitado a una de las famosas clases de los martes de Charcot y este se presentará junto a su ayudante Émilie para escuchar el caso que tiene para ellos: Buscar a una interna desaparecida y no a cualquiera, a su favorita. Deben encontrar antes del próximo martes a Louise Augustine Gleizes.Cuanto más indaguen más complejo se volverá el caso.¿Qué ocurre tras los muros de La Salpêtrière?·Émilie (Eli): https://bsky.app/profile/aldery.bsky.social·Winston (Adri): https://bsky.app/profile/did:plc:up7j4vfnfoet226ygqoxbyolhttps://www.twitch.tv/inthemoodforroll

[REDIFFUSION] Bienvenue dans Les Fabuleux Destins. Aujourd'hui, je vais vous parler d'une enquête médicale qui aura duré plus de 10 ans. À la fois fascinante et dramatique, elle n'aurait jamais pu être résolue sans l'intervention d'un spécialiste américain et la persévérance d'une neurologue française. Son nom : le mystère du village de Montchavin. Entre anomalies et raisonnement scientifique, découvrez son palpitant destin. L'énigme médicale Emmeline Lagrange, spécialiste en neurologie, reçoit une patiente : une femme d'une quarantaine d'années, originaire de Montchavin, qui souffre de douleurs musculaires. Après un examen approfondi, la docteure fait une découverte tragique. Le diagnostic est sans appel : c'est une sclérose latérale amyotrophique, autrement appelée “maladie de Charcot”. Après quelques appels téléphoniques pour se renseigner sur cette pathologie auprès de ses collègues, Emmeline Lagrange découvre qu'un nombre inexplicable d'habitants de Montchavin sont touchés par ce fléau. Cela ne peut pas être une coïncidence. Commence alors une véritable enquête médicale...  Un podcast Bababam Originals Ecriture : Elie Olivennes Voix : Andréa Brusque Learn more about your ad choices. Visit megaphone.fm/adchoices

"J'aimerais vous raconter comment je tente de transformer un ciel orageux en un soleil radieux. Et comment une telle maladie peut nous offrir un passe-droit pour une vie incroyable." Lorène Vivier a 35 ans quand elle apprend qu'elle est atteinte de la maladie de Charcot, une pathologie neurodégénérative, incurable et mortelle. À ce moment-là, deux choix se présentent à elle : soit elle se jette d'un pont, soit elle prend son sac à dos et se met en marche. Lorène choisit la deuxième option. Son sac à dos, c'est le symbole de son courage, de sa joie infatigable et de son désir de faire avancer les choses. Elle a décidé qu'elle n'avait plus le temps d'attendre le bon moment et que sa maladie n'était pas un mal à combattre mais plutôt une nouvelle aventure à vivre. Une très belle lueur ! Bonne écoute. ✨ 

Descubre Cómo Entender de Verdad Un Trastorno de Ansiedad y Tomar Acción En Nuestro Curso Gratuito El Mapa de La Ansiedad: https://escuelaansiedad.com/Cursos/el-mapa-de-la-ansiedad Episodio Especial | Sigmund Freud: El Hombre Detrás del Mito ¿Quién fue realmente Sigmund Freud? ¿Un visionario, un obstinado, un genio de la mente... o todas las anteriores? Hoy en La Teoría de la Mente o en AMADAG TV, nos sumergimos en la vida del creador del psicoanálisis, en un recorrido fascinante que va mucho más allá del típico “complejo de Edipo” o los famosos lapsus freudianos. Freud no solo propuso una terapia. Inventó un nuevo lenguaje para hablar de nosotros mismos. Cambió la forma en que nos miramos, soñamos y hasta sufrimos. Pero detrás del mito, había un hombre con luces y muchas sombras. Un científico atrapado entre la rigidez de la medicina y la ambición de explorar el alma humana. En este episodio recorremos: Sus inicios como neurólogo y defensor de la cocaína como tratamiento médico Su revolución personal en París al ver cómo las palabras pueden sanar el cuerpo La creación del psicoanálisis y sus autoexploraciones valientes y dolorosas El escándalo de la sexualidad infantil y el complejo de Edipo Sus disputas intelectuales con Jung y Adler, y la tragedia del exilio nazi El legado cultural y psicológico que aún marca nuestra forma de pensar en el siglo XXI ¿Sabías que Freud hablaba español y formó una sociedad secreta llamada Academia Castellana? ¿O que uno de sus mayores errores fue intentar curar una adicción… provocando otra aún peor? Este viaje no solo es un retrato histórico. Es una mirada al nacimiento del inconsciente moderno, a la lucha interna entre el ello, el superyó y el yo, y a cómo la ansiedad se convierte en la señal de una mente en conflicto. Porque, como bien señala Freud, "lo que no se hace consciente, se repite como destino." Y aunque muchas de sus ideas hayan sido criticadas o incluso refutadas científicamente, su valor interpretativo y simbólico sigue siendo una brújula cultural. Nos ofreció una forma de narrar nuestras heridas. Y eso… sigue siendo poderoso. Enlaces Importantes para Seguir Explorando: Nuestra Escuela de Ansiedad: www.escuelaansiedad.com Nuestro nuevo libro - El Mapa de la Ansiedad: www.elmapadelaansiedad.com Visita nuestra Web: www.amadag.com Facebook: https://www.facebook.com/Asociacion.Agorafobia/ Instagram: https://www.instagram.com/amadag.psico/ ▶️ YouTube - AMADAG TV: https://www.youtube.com/channel/UC22fPGPhEhgiXCM7PGl68rw Palabras clave (SEO): Freud,psicoanálisis,ansiedad,salud mental,psicología moderna,historia de la psicología,el inconsciente,teoría freudiana,complejo de Edipo,cocaína Freud,Charcot,autoanálisis,sueños Freud,represión,sexualidad infantil,psicología clínica,mecanismos de defensa,ego,ello,superyó,neuropsicoanálisis,Sigmund Freud historia,Freud y Jung,psicoterapia Hashtags sugeridos: #Freud #Psicoanálisis #Ansiedad #Psicología #SaludMental #TeoríaDeLaMente

Descubre Cómo Entender de Verdad Un Trastorno de Ansiedad y Tomar Acción en Nuestro Curso Gratuito: El Mapa de La Ansiedad https://escuelaansiedad.com/Cursos/el-mapa-de-la-ansiedad ️ Episodio: "El Inconsciente: La Historia de una Sombra que nos Gobierna" ¿Alguna vez has sentido que no estás completamente al mando de tu propia mente? ¿Como si una parte de ti decidiera por ti, en silencio? En este episodio, nos sumergimos en una de las ideas más fascinantes y transformadoras del siglo XX: el inconsciente. A través de un viaje que empieza con Herbart, sigue con las demostraciones hipnóticas de Charcot, se profundiza con la disociación de Janet y explota en un mapa completo con Freud, exploramos cómo esta idea ha influido en nuestra cultura, la ciencia, la medicina, la literatura... y nuestra forma de entender quiénes somos. Verás cómo el inconsciente pasó de ser una metáfora filosófica a una poderosa explicación clínica. Aprenderás: Por qué Herbart comparó las ideas con fuerzas que luchan entre sí. Cómo Charcot transformó los síntomas inexplicables en un espectáculo clínico. Qué descubrió Janet sobre la disociación y los recuerdos traumáticos. Cómo Freud convirtió el inconsciente en el motor central de nuestra vida psíquica... ¡y cultural! Y por qué incluso hoy, en plena era de la neurociencia, el inconsciente sigue presente, aunque haya cambiado de forma. Desde la neurología a la psicología, pasando por la hipnosis, la cultura pop y las redes sociales, este episodio conecta lo visible y lo invisible, lo racional y lo simbólico, para ayudarte a entender por qué a veces no eres tú quien conduce del todo tu vida. Porque conocer tu inconsciente no es una condena, sino una pista para recuperar el timón. Recursos Recomendados: Nuestra escuela de ansiedad: www.escuelaansiedad.com Nuestro nuevo libro: www.elmapadelaansiedad.com Visita nuestra página web: http://www.amadag.com Facebook: https://www.facebook.com/Asociacion.Agorafobia/ Instagram: https://www.instagram.com/amadag.psico/ YouTube Amadag TV: https://www.youtube.com/channel/UC22fPGPhEhgiXCM7PGl68rw 25 Keywords SEO: inconsciente,psicología,Freud,Charcot,Janet,Herbart,teoría del inconsciente,disociación,trastornos mentales,histeria,psicoanálisis,neurociencia moderna,historia de la psicología,síntomas psicosomáticos,hipnosis médica,origen del psicoanálisis,terapia psicológica,trauma emocional,salud mental,ansiedad inconsciente,pensamiento automático,conductismo,sugestión,mente subconsciente,procesos mentales ocultos Hashtags: #Psicología #Inconsciente #Freud #SaludMental #LaTeoríaDeLaMente #AmadagTV

À Davos, les géants de la tech ont donné le ton pour l'année à venir : intelligence artificielle, robots, emploi et souveraineté numérique. Entre annonces spectaculaires, promesses et zones d'ombre, décryptage d'une semaine où la technologie s'est imposée au sommet du pouvoir.

Avicenne, Babinski, Charcot, Galien, Koch, Laennec, Pasteur... Ces personnalités ont marqué durablement l'histoire de la médecine. Quelles sont les autres figures, moins connues du grand public, qui ont su influencer le monde médical ? Nous parlons de leurs parcours et de leurs avancées, qui peuvent parfois, aujourd'hui, être remises en question. [Rediffusion] Certains ont donné leur nom à des rues, à des stations de métro, ou à des vaccins. D'autres, connus de leurs seuls contemporains, sont aujourd'hui complètement tombés dans l'oubli. Quant aux derniers, ils n'ont jamais connu la célébrité, alors qu'ils ont sauvé d'innombrables vies. Eux, ce sont les héros de la médecine.  Leur héritage scientifique reste d'actualité, que ce soit pour lutter contre les infections, mettre des enfants au monde, combattre le cancer, soulager la dépression ou diagnostiquer une maladie génétique.   Yersin, Hippocrate et Marie Curie Itinéraires d'hommes célèbres (Alexandre Yersin, Hippocrate ou Zénon Drohocki) et de femmes, dont la détermination et l'énergie ont eu raison des obstacles et des préjugés, faisant d'elles de véritables pionnières dans le domaine de la santé (comme Madeleine Brès ou Marthe Gautier), et pourtant, la renommée de ces dernières a rarement atteint celle de leurs confrères, exception faite bien sûr, de la double nobélisée, Marie Curie.   Parcours de vie et découvertes scientifiques  Les travaux de ces aventuriers de la santé sont toujours à l'ordre du jour pour soigner, partout dans le monde et leurs parcours parfois inattendus, se racontent comme un roman…  Des personnalités qui ont tracé leur sillon en apportant de nouveaux savoir-faire, de nouvelles techniques, en créant des outils ou une compréhension, qui ont bouleversé la pratique de la médecine : césarienne, conseils pour l'allaitement maternel, électroconvulsivothérapie (les électrochocs), découverte de la Trisomie 21, du Bacille de la peste, culture du quinquina contre le paludisme...  Évoquer le parcours et les découvertes de ces héros de la médecine, c'est aussi souligner l'importance de la recherche scientifique et d'avancées parfois anciennes, qui ont toute leur place, aujourd'hui encore dans la pratique médicale et continuent de sauver des vies.   Avec :  Pr Gilles Pialoux, chef du Service des Maladies Infectieuses et Tropicales à l'Hôpital Tenon (APHP) et professeur à Sorbonne Universités à Paris. Auteur de l'ouvrage Admirations : Sept héros de la médecine, aux éditions Perrin  Pr Fatimata Ly, dermatologue et vénérologue, professeur à la Faculté de médecine, de pharmacie et d'odontostomatologie de l'Université Cheikh Anta Diop de Dakar. Médecin-chef du service de Dermatologie de l'Institut d'Hygiène Sociale de Dakar. Présidente de la société sénégalaise de dermatologie vénéréologie. Co-auteure de l'ouvrage Elles étaient là, les pionnières de la santé !, aux éditions Nara Thanh-Hà Tran, journaliste au service vietnamien de RFI. Programmation musicale :  ► Michael Kiwanuka – Hero ► Trio Mocotó – O xangô.    

Avicenne, Babinski, Charcot, Galien, Koch, Laennec, Pasteur... Ces personnalités ont marqué durablement l'histoire de la médecine. Quelles sont les autres figures, moins connues du grand public, qui ont su influencer le monde médical ? Nous parlons de leurs parcours et de leurs avancées, qui peuvent parfois, aujourd'hui, être remises en question. [Rediffusion] Certains ont donné leur nom à des rues, à des stations de métro, ou à des vaccins. D'autres, connus de leurs seuls contemporains, sont aujourd'hui complètement tombés dans l'oubli. Quant aux derniers, ils n'ont jamais connu la célébrité, alors qu'ils ont sauvé d'innombrables vies. Eux, ce sont les héros de la médecine.  Leur héritage scientifique reste d'actualité, que ce soit pour lutter contre les infections, mettre des enfants au monde, combattre le cancer, soulager la dépression ou diagnostiquer une maladie génétique.   Yersin, Hippocrate et Marie Curie Itinéraires d'hommes célèbres (Alexandre Yersin, Hippocrate ou Zénon Drohocki) et de femmes, dont la détermination et l'énergie ont eu raison des obstacles et des préjugés, faisant d'elles de véritables pionnières dans le domaine de la santé (comme Madeleine Brès ou Marthe Gautier), et pourtant, la renommée de ces dernières a rarement atteint celle de leurs confrères, exception faite bien sûr, de la double nobélisée, Marie Curie.   Parcours de vie et découvertes scientifiques  Les travaux de ces aventuriers de la santé sont toujours à l'ordre du jour pour soigner, partout dans le monde et leurs parcours parfois inattendus, se racontent comme un roman…  Des personnalités qui ont tracé leur sillon en apportant de nouveaux savoir-faire, de nouvelles techniques, en créant des outils ou une compréhension, qui ont bouleversé la pratique de la médecine : césarienne, conseils pour l'allaitement maternel, électroconvulsivothérapie (les électrochocs), découverte de la Trisomie 21, du Bacille de la peste, culture du quinquina contre le paludisme...  Évoquer le parcours et les découvertes de ces héros de la médecine, c'est aussi souligner l'importance de la recherche scientifique et d'avancées parfois anciennes, qui ont toute leur place, aujourd'hui encore dans la pratique médicale et continuent de sauver des vies.   Avec :  Pr Gilles Pialoux, chef du Service des Maladies Infectieuses et Tropicales à l'Hôpital Tenon (APHP) et professeur à Sorbonne Universités à Paris. Auteur de l'ouvrage Admirations : Sept héros de la médecine, aux éditions Perrin  Pr Fatimata Ly, dermatologue et vénérologue, professeur à la Faculté de médecine, de pharmacie et d'odontostomatologie de l'Université Cheikh Anta Diop de Dakar. Médecin-chef du service de Dermatologie de l'Institut d'Hygiène Sociale de Dakar. Présidente de la société sénégalaise de dermatologie vénéréologie. Co-auteure de l'ouvrage Elles étaient là, les pionnières de la santé !, aux éditions Nara Thanh-Hà Tran, journaliste au service vietnamien de RFI. Programmation musicale :  ► Michael Kiwanuka – Hero ► Trio Mocotó – O xangô.    

Pour cette fin d'année, Contre-addictions vous propose de découvrir ou redécouvrir des épisodes qui ont marqué les prmières saisons du podcast.

Histoire d'une vie est un podcast issu des archives d'Europe 1.- Présentation : Marc Menant - Production et rédaction : Clara Leger- Réalisation : Julien Tharaud - Diffusion : Clara Ménard Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Neuropathic (Charcot) Arthropathy from the Orthopedics section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

Alors que cette semaine marquait la journée internationale de lutte contre les violences faites aux femmes, voilà ma pierre à l'édifice. Un entretien avec l'essayiste et documentariste Pauline Chanu, qui vient de publier un essai puissant : Sortir de la Maison Hantée. (La Découverte).Vous vous apprêtez à écouter le premier épisode hanté de Folie Douce, préparez-vous.Lorsque le festival Offscreen m'a proposé d'enregistrer un entretien dans la chapelle de la Salpêtrière, à Paris, j'ai tout de suite su que je devais m'y entretenir avec Pauline Chanu pour revenir avec elle sur les violences qu'ont subi, à la fin du 19ème siècle, les « hystériques » du professeur Charcot, des femmes dont la folie servait de spectacle aux intellectuels parisiens et dont le corps, sexualisé à outrance, s'imprime encore dans nos imaginaires.Alors on a fait ça. On a parlé de ces patientes d'hier et de leurs héritières, les psychiatrisées, d'aujourd'hui. On a parlé d'Augustine, de Freud, mais aussi de Britney Spears, de Marie Trintignant. On a aussi parlé des raisons personnelles qui ont poussé Pauline Chanu à se pencher sur cette question.Car Pauline, en s'appuyant sur des entretiens nombreux, avec des femmes victimes, démontre que l'imaginaire de l'hystérique infuse encore les mentalités aujourd'hui, y compris au sein du monde médical, où le diagnostic continue d'être prononcé de façon plus ou moins assumé. Ce terme prend parfois la forme de qualificatifs différents comme “borderline”, mais sert toujours à rabaisser la parole des femmes. Et toujours, Pauline Chanu est limpide à ce sujet, il y a derrière la femme dite « hystérique » un « hystériseur », c'est-à-dire un homme violent qui pratique le “gaslighting” car il a tout interêt à ce que la parole de cette femme soit totalement décrédibilisée.Il régnait une atmosphère très particulière pendant notre échange, qui persiste, je le sais, à l'écoute de l'épisode. J'espère au fond de moi que quelques patientes du professeur Charcot s'étaient glissées dans la chapelle lors de cet enregistrement où nous leur avons fait justice.Je remercie infiniment Pauline Chanu d'avoir accepté mon invitation. Et merci au festival Offscreen de nous avoir donné la possibilité de vivre ce moment unique.Photo : Romy Alizée

Avicenne, Babinski, Charcot, Galien, Koch, Laennec, Pasteur... Ces personnalités ont marqué durablement l'histoire de la médecine. Quelles sont les autres figures, moins connues du grand public, qui ont su influencer le monde médical ? Nous parlons de leurs parcours et de leurs avancées, qui peuvent parfois, aujourd'hui, être remises en question. Certains ont donné leur nom à des rues, à des stations de métro, ou à des vaccins. D'autres, connus de leurs seuls contemporains, sont aujourd'hui complètement tombés dans l'oubli. Quant aux derniers, ils n'ont jamais connu la célébrité, alors qu'ils ont sauvé d'innombrables vies. Eux, ce sont les héros de la médecine.  Leur héritage scientifique reste d'actualité, que ce soit pour lutter contre les infections, mettre des enfants au monde, combattre le cancer, soulager la dépression ou diagnostiquer une maladie génétique.   Yersin, Hippocrate et Marie Curie Itinéraires d'hommes célèbres (Alexandre Yersin, Hippocrate ou Zénon Drohocki) et de femmes, dont la détermination et l'énergie ont eu raison des obstacles et des préjugés, faisant d'elles de véritables pionnières dans le domaine de la santé (comme Madeleine Brès ou Marthe Gautier), et pourtant, la renommée de ces dernières a rarement atteint celle de leurs confrères, exception faite bien sûr, de la double nobélisée, Marie Curie.   Parcours de vie et découvertes scientifiques  Les travaux de ces aventuriers de la santé sont toujours à l'ordre du jour pour soigner, partout dans le monde et leurs parcours parfois inattendus, se racontent comme un roman…  Des personnalités qui ont tracé leur sillon en apportant de nouveaux savoir-faire, de nouvelles techniques, en créant des outils ou une compréhension, qui ont bouleversé la pratique de la médecine : césarienne, conseils pour l'allaitement maternel, électroconvulsivothérapie (les électrochocs), découverte de la Trisomie 21, du Bacille de la peste, culture du quinquina contre le paludisme...  Évoquer le parcours et les découvertes de ces héros de la médecine, c'est aussi souligner l'importance de la recherche scientifique et d'avancées parfois anciennes, qui ont toute leur place, aujourd'hui encore dans la pratique médicale et continuent de sauver des vies.   Avec :  Pr Gilles Pialoux, chef du Service des Maladies Infectieuses et Tropicales à l'Hôpital Tenon (APHP) et professeur à Sorbonne Universités à Paris. Auteur de l'ouvrage Admirations : Sept héros de la médecine, aux éditions Perrin  Pr Fatimata Ly, dermatologue et vénérologue, professeur à la Faculté de médecine, de pharmacie et d'odontostomatologie de l'Université Cheikh Anta Diop de Dakar. Médecin-chef du service de Dermatologie de l'Institut d'Hygiène Sociale de Dakar. Présidente de la société sénégalaise de dermatologie vénéréologie. Co-auteure de l'ouvrage Elles étaient là, les pionnières de la santé !, aux éditions Nara Thanh-Hà Tran, journaliste au service vietnamien de RFI. Programmation musicale :  ► Michael Kiwanuka – Hero ► Trio Mocotó – O xangô.    

Avicenne, Babinski, Charcot, Galien, Koch, Laennec, Pasteur... Ces personnalités ont marqué durablement l'histoire de la médecine. Quelles sont les autres figures, moins connues du grand public, qui ont su influencer le monde médical ? Nous parlons de leurs parcours et de leurs avancées, qui peuvent parfois, aujourd'hui, être remises en question. Certains ont donné leur nom à des rues, à des stations de métro, ou à des vaccins. D'autres, connus de leurs seuls contemporains, sont aujourd'hui complètement tombés dans l'oubli. Quant aux derniers, ils n'ont jamais connu la célébrité, alors qu'ils ont sauvé d'innombrables vies. Eux, ce sont les héros de la médecine.  Leur héritage scientifique reste d'actualité, que ce soit pour lutter contre les infections, mettre des enfants au monde, combattre le cancer, soulager la dépression ou diagnostiquer une maladie génétique.   Yersin, Hippocrate et Marie Curie Itinéraires d'hommes célèbres (Alexandre Yersin, Hippocrate ou Zénon Drohocki) et de femmes, dont la détermination et l'énergie ont eu raison des obstacles et des préjugés, faisant d'elles de véritables pionnières dans le domaine de la santé (comme Madeleine Brès ou Marthe Gautier), et pourtant, la renommée de ces dernières a rarement atteint celle de leurs confrères, exception faite bien sûr, de la double nobélisée, Marie Curie.   Parcours de vie et découvertes scientifiques  Les travaux de ces aventuriers de la santé sont toujours à l'ordre du jour pour soigner, partout dans le monde et leurs parcours parfois inattendus, se racontent comme un roman…  Des personnalités qui ont tracé leur sillon en apportant de nouveaux savoir-faire, de nouvelles techniques, en créant des outils ou une compréhension, qui ont bouleversé la pratique de la médecine : césarienne, conseils pour l'allaitement maternel, électroconvulsivothérapie (les électrochocs), découverte de la Trisomie 21, du Bacille de la peste, culture du quinquina contre le paludisme...  Évoquer le parcours et les découvertes de ces héros de la médecine, c'est aussi souligner l'importance de la recherche scientifique et d'avancées parfois anciennes, qui ont toute leur place, aujourd'hui encore dans la pratique médicale et continuent de sauver des vies.   Avec :  Pr Gilles Pialoux, chef du Service des Maladies Infectieuses et Tropicales à l'Hôpital Tenon (APHP) et professeur à Sorbonne Universités à Paris. Auteur de l'ouvrage Admirations : Sept héros de la médecine, aux éditions Perrin  Pr Fatimata Ly, dermatologue et vénérologue, professeur à la Faculté de médecine, de pharmacie et d'odontostomatologie de l'Université Cheikh Anta Diop de Dakar. Médecin-chef du service de Dermatologie de l'Institut d'Hygiène Sociale de Dakar. Présidente de la société sénégalaise de dermatologie vénéréologie. Co-auteure de l'ouvrage Elles étaient là, les pionnières de la santé !, aux éditions Nara Thanh-Hà Tran, journaliste au service vietnamien de RFI. Programmation musicale :  ► Michael Kiwanuka – Hero ► Trio Mocotó – O xangô.    

Voici un lien pour vous demander une petite contribution afin de m'encourager ou me remercier de créer ce genre d'épisodes qui j'espère vous aident

Comment vivre pleinement une histoire d'amour quand la vie a tout fait pour bousculer les certitudes ?Quand Hugo apprend que la femme qu'il aime est atteinte de la maladie de Charcot, il choisit de vivre au jour le jour, sans jamais laisser la maladie altérer ce qu'ils partagent.Après le choc, ils ont trouvé la force de rester heureux, autrement, ensemble… jusqu'au bout. L'histoire que vous allez entendre est si belle, et vous allez voir, elle est pleine de joie, et de vie.Clémentine De La Grange a réalisé cet épisode, Stéphane Bidart l'a monté et mis en musique. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Auditrice : - Atteinte de la maladie de Charcot, Lorène continue de croquer la vie à pleines dents https://www.editions-tredaniel.com/la-vie-est-belle-essaie-la-p-12250.html https://www.arsla.org/ Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Welcome to Rendering Unconscious – the Gradiva award-winning podcast about psychoanalysis & culture, with me, Dr Vanessa Sinclair. https://renderingunconscious.substack.com RU364: KIERAN SAINT LEONARD ON MAGIC, MUSIC, THE MUSE & THE GOLDEN HOUR https://renderingunconscious.substack.com/p/ru364-kieran-saint-leonard-on-the Rendering Unconscious episode 364. Rendering Unconscious welcomes Kieran Saint Leonard to the podcast! He's here to talk about his new book A Muse from Hyperidean Press. https://www.hyperideanpress.com/shop/p/a-muse-by-kieran-saint-leonard-pre-order Be sure to check out his new album The Golden Hour. https://xelon.ffm.to/slgoldenhour On this episode Kieran Saint Leonard discusses his novel “A Muse,” which blends autobiographical elements with fictional elements. The book features a protagonist inspired by his own experiences, including moving into a Gothic church in the UK and later to Los Angeles. Kieran emphasizes the book's allegorical nature, influenced by Carl Jung's ideas and the occult. He describes the writing process as therapeutic, helping him integrate and heal from past events. Kieran also discusses his musical persona Saint Leonard, including a recent album “The Golden Hour” that rings of Berlin-era Bowie, and plans for upcoming readings in the UK and New York. Follow Saint Leonard on Instagram https://www.instagram.com/thesaintleonard/ Spotify https://open.spotify.com/artist/4rLGeCqJG3jVLC0t1njg61?si=J31X79hrRya32PMO4Idt_g Linktree https://linktr.ee/thesaintleonard News & updates: The next event for RU Center for Psychoanalysis is coming up Saturday, October 18th! Join me for the second installment of An Introduction to Psychoanalysis. Register by becoming a paid subscriber at RU Center for Psychoanalysis: https://rucenterforpsychoanalysis.substack.com You may watch the recording of the first class HERE: https://rucenterforpsychoanalysis.substack.com/t/classes We covered Freud's early life, family dynamics and how they influenced his later theories, as well as his work with Charcot and Breuer, culminating in Studies on Hysteria (1895). In the second class we will look at Freud's correspondence with Fliess and how it functioned as a self-analysis; we'll focus on The Interpretation of Dreams (1900) and the dream of Irma's Injection, and discuss major works including The Psychopathology of Everyday Life (1901), Jokes and Their Relation to the Unconscious (1905), Fragment of a Case of Hysteria (1905), and Three Essays of the Theory of Sexuality (1905). There will be plenty of time for discussion and free association so feel free to bring your thoughts and dreams. Then on Saturday, October 25th Mary Wild presents her work on Feminine Jouissance through the exploration of cinema, specifically the films Possession(1981) dir. Andrzej Żuławski, Paranormal Activity (2007) dir. Oren Peli, and Kiss of the Damned (2012) dir. Alexandra Cassavetes. https://www.eventbrite.co.uk/e/feminine-jouissance-in-horror-cinema-tickets-1754755814879?aff=oddtdtcreator All proceeds raised go directly toward paying our presenter(s). Thank you for your support! Both events meet online for 2 hours beginning at 9AM Vancouver/ 12PM noon NYC/ 5PM London/ 18:00 Stockholm/ 19:00 Beirut. These events will be recorded and archived at RU Center for Psychoanalysis for those who can't attend live. See you soon!

Welcome to Rendering Unconscious – the Gradiva award-winning podcast about psychoanalysis & culture, with me, Dr Vanessa Sinclair. https://renderingunconscious.substack.com RU363: JARED WARE FROM MILLENNIALS ARE KILLING CAPITALISM: https://renderingunconscious.substack.com/p/ru363-jared-ware-from-millennials Rendering Unconscious episode 363. Rendering Unconscious welcomes Jared Ware from Millennials are Killing Capitalism to the podcast! Follow MAKCapitalism at YouTube https://www.youtube.com/@MAKCapitalism Instagram https://www.instagram.com/makcapitalism/ Patreon https://www.patreon.com/millennialsarekillingcapitalism Linktree https://linktr.ee/makcapitalism Support Lifeline4Gaza https://www.instagram.com/lifeline4gaza/ On this episode, Jared discusses his work with the Millennials are Killing Capitalism podcast and how it has evolved over the past 8 years. He discusses reoccurring guests who have contributed to building the MAKCapitalism community, including Lara Sheehi, Abdaljawad Omar, and Stephen Sheehi, and his persistent work addressing imperialism and the ongoing genocide in Gaza. He also discusses MAKCapitalism's current study group on Ali Kadri's “The Accumulation of Waste,” which explores capitalism's role in the production of waste and war, as well as the propaganda machine that is Hollywood in his “Imperial 80s” series with Mtume Gant. Check out these episodes of MAKCapitalism: Abdaljawad Omar & Lara Sheehi: 2 Years of Resistance, 2 Years of Genocide https://www.youtube.com/live/vocPxGxcIjg?si=UaCPDDMXpwwbHdUq ‘A Nightmare on Elm Street' featuring Renee Johnston | The Imperial ‘80s Episode 12 https://www.youtube.com/live/6SFoqu8PBGA?si=ZnhNiX9GLHpxCC6e Millennials Are Killing Capitalism's 8 Year Anniversary Extravaganza! https://www.youtube.com/live/o_h0O0LtR9Y?si=aLu5CIipOdxkPlf- “War Is the Basis of Accumulation” - Ali Kadri on Genocide, Waste, Imperialism, and the Commodification of Death https://millennialsarekillingcapitalism.libsyn.com/war-is-the-basis-of-accumulation-ali-kadri-on-genocide-waste-imperialism-and-the-commodification-of-death News and updates: The next event for RU Center for Psychoanalysis is coming up Saturday, October 18th! Join me for the second installment of An Introduction to Psychoanalysis. Register by becoming a paid subscriber at RU Center for Psychoanalysis: https://rucenterforpsychoanalysis.substack.com You may watch the recording of the first class HERE: https://rucenterforpsychoanalysis.substack.com/t/classes We covered Freud's early life, family dynamics and how they influenced his later theories, as well as his work with Charcot and Breuer, culminating in Studies on Hysteria (1895). In the second class we will look at Freud's correspondence with Fliess and how it functioned as a self-analysis; we'll focus on The Interpretation of Dreams (1900) and the dream of Irma's Injection, and discuss major works including The Psychopathology of Everyday Life (1901), Jokes and Their Relation to the Unconscious (1905), Fragment of a Case of Hysteria (1905), and Three Essays of the Theory of Sexuality (1905). There will be plenty of time for discussion and free association so feel free to bring your thoughts and dreams. See you soon!

“The Magic Circle: Swedenborgian PTK” - a new joint investigation from The Return of the Repressed and ParaPower Mapping.Subscribe to the PPM & The Return of the Repressed Patreons to support our work: patreon.com/ParaPowerMappingpatreon.com/TheReturnOfTheRepressedKlonny and Marcus have arisen from their dread slumber to once again haunt the Tantric Satanic byways of the life of Sigvard Thurneman and his band of carjacking hypnotic gangsters known as the Salaligan, once again encircling the Manhunter's misguided quest for the "perfect crime" as we introduce the psychoanalytic and occulted ferment out of which Den Magiska Cirkeln took form. This episode, paying special heed to Freud, Charcot, the carnivalesque traveling circus as proto-MK staging ground, "Diamonds Are Forever", the looming shadow of early Luciferian Ben Kadosh aka Carl William Hansen (one linkage between Eliphas Levi, the French Satanic Symbolist set of the Belle Epoque, and the nascent underworld of Nazi occultism), the "Little Berlin" of Copenhagen, and the dire Danish keep of Andorskov that served as long time home to the Knights Hospitaller.Tracks & Clips:| 1900 - Den Minsta Av Segrar1900 - En Gång Ägde Vi Hela Jorden1900 - Gud Är En Eld Inuti Huvudet 1900 - Jag Har Hört Om En Stad Ovan Molnen

Neste episódio de Freud Que Eu Te Escuto, apresento uma coletânea de pequenos escritos de Freud, que vão desde prefácios a livros de colegas até cartas pessoais e declarações ocasionais.Textos lidos neste episódio:Prólogo ao relatório sobre a Policlínica Psicanalítica de Berlim, de Max EitingonCarta a Luis López-Ballesteros y de TorresCarta a Fritz WittelsDeclaração sobre CharcotPrólogo a A Juventude Abandonada, de August AichhornObituário de Joseph BreuerExcerto de uma carta sobre o judaísmoMensagem na inauguração da Universidade Hebraica de JerusalémFreud escreve, ao recordar seu mestre em Paris:“Entre muitos ensinamentos que, no passado, em 1886, me foram prodigalizados por Charcot na Salpêtrière, dois me deixaram uma impressão bastante profunda: que não devemos nos cansar de sempre considerar novamente os mesmos problemas e que não devemos nos preocupar com a oposição geral, se trabalhamos com honestidade.”Em outro momento, refletindo sobre a educação de crianças desamparadas, ele afirma:“Se educador aprendeu a análise mediante a experiência em sua própria pessoa e está em condição de aplicá-la a casos fronteiriços, então se deve permitir a ele o exercício da psicanálise e não lhe pôr nisso obstáculos por motivos mesquinhos.”E, em tom autobiográfico, a propósito de Breuer, escreve:“Ele disse naquele momento: ‘acho que é a coisa mais importante que nós dois teremos a comunicar ao mundo'.”Reunidos, esses textos revelam um Freud íntimo, memorialista e também comprometido com o futuro da psicanálise, seja na formação de novos analistas, na educação, ou na fundação de instituições.

durée : 00:37:50 - Le 18/20 · Le téléphone sonne - 1,4 millions de Français sont touchés par la maladie d'Alzheimer (ou apparentées). Parkinson, Sclérose en plaques, Charcot : les maladies neurodégénératives sont malheureusement très nombreuses et la médecine a beau faire de contants progrès, les malades et leurs familles ont toujours besoin d'aide. Vous aimez ce podcast ? Pour écouter tous les autres épisodes sans limite, rendez-vous sur Radio France.

Huge thanks to everyone who attended the first An Introduction to Psychoanalysis class live! It was such a fun time. Here are some clips! To access the full recording, become a paid subscriber at RU Center for Psychoanalysis Substack: https://rucenterforpsychoanalysis.substack.com For this first class on September 13th, I presented on Freud's early development and the Zeitgeist of the times culturally and politically in which he grew up, came of age, and began his studies at university. We took a look at Freud's early research interests, his time working with Charcot and the influence it had on his work, and delved into his early work with Breuer, culminating in the publication of Studies on Hysteria (1895). https://rucenterforpsychoanalysis.substack.com/p/an-introduction-to-psychoanalysis-86f News and events: Coming up October 4th, the next event in The Queerness of Psychoanalysis series of events, Simone Atenea Medina Polo presents her work on Tiresias as the Patron Saint of Psychoanalysis. Register here: https://wise.com/pay/r/t6ZRZPyG8KgFt34 All paid subscribers to RU Center for Psychoanalysis will automatically be enrolled in and receive the zoom links to attend events in the Intro to Psychoanalysis and Queerness of Psychoanalysis series. Additionally all Intro to Psychoanalysis classes and Queerness of Psychoanalysis events will be recorded and archived at RU Center for Psychoanalysis Substack. To enroll, simply become a paid subscriber: https://rucenterforpsychoanalysis.substack.com Recorded events can be found here: https://rucenterforpsychoanalysis.substack.com/t/classes The next Intro to Psychoanalysis class meets Saturday, October 18th. See you there! Feel free to contact me directly anytime with questions or comments: https://www.drvanessasinclair.net/contact/ Here's my linktree: https://linktr.ee/rawsin_ Rendering Unconscious Podcast received the Gradiva Award for Digital Media from the National Association for the Advancement for Psychoanalysis (NAAP). Thank you for listening to the Rendering Unconscious Podcast and for reading the Rendering Unconscious anthologies. And thank you so much for supporting this work by being a paid subscriber at Substack. It makes my work possible. If you are so far a free subscriber, thanks to you too. Please consider becoming a paid subscriber to gain access to all the material on the site, including all future and archival podcast episodes. If you would like information about entering into psychoanalytic treatment with me or have other questions, please feel free to contact me: www.drvanessasinclair.net/contact/ Thank you.

Tics are movements or sounds that are quick, recurrent, and nonrhythmic. They fluctuate over time and can be involuntary or semivoluntary. Although behavioral therapy remains the first-line treatment, modifications to comprehensive behavioral intervention have been developed to make treatment more accessible. In this episode, Casey Albin, MD, speaks with Jessica Frey, MD, author of the article “Tourette Syndrome and Tic Disorders” in the Continuum® August 2025 Movement Disorders issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Frey is an assistant professor of neurology, Movement Disorders Fellowship Program Director, and Neurology Student Clerkship Director at the Rockefeller Neuroscience Institute in the department of neurology at West Virginia University in Morgantown, West Virginia. Additional Resources Read the article: Tourette Syndrome and Tic Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Transcript Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Albin: Hi all, this is Dr Casey Albin. Today I'm interviewing Dr Jessica Frey about her article Tourette Syndrome and Tic Disorders, which appears in the August 2025 Continuum issue on movement disorders. Dr Frey, thank you so much for being here, and welcome to the podcast. I'd love for you to briefly introduce yourself to our audience. Dr Frey: Thank you for having me here today. My name is Jessica Frey, and I am a movement disorder specialist at West Virginia University. I'm also the movement disorder fellowship director, as well as the neurology clerkship student director. Dr Albin: Dr. Frey, I feel like this was one of the things I actually had no exposure to as a resident. For trainees that kind of want to get a better understanding of how these are managed, what kind of counseling you do, what kind of interventions you're using, how can they get a little bit more exposure? Dr Frey: That's a great question, and I actually had a similar experience to you. I did not see that many patients with Tourette syndrome while I was in my residency training. I got a lot more exposure during my fellowship training, and that's when I actually fell in love with that patient population, caring for them, seeing them be successful. I think it depends on the program that you're in. During the pediatric neurology rotation might be your best bet to getting exposure to patients with Tourette syndrome, since a lot of them are going to be diagnosed when they're quite young, and sometimes they'll even continue to follow through young adulthood in the pediatric neurology clinic. However, up to 20% of patients with Tourette syndrome will have persistent tics during adulthood. And so, I think it is important for neurology trainees to understand how to manage them, understand what resources are out there. So, if you have an interest in that, absolutely try to follow either in the pediatric neurology department, or if you have a movement disorder program that has a Tourette clinic or has a movement disorder specialist who has an interest in Tourette syndrome, definitely try to hang out with them. Get to know that patient population, and educate yourself as much as you're able to educate the patients as well. Dr Albin: Yeah, I think that's fantastic advice. You wrote a fantastic article, and it covers a lot of ground. And I think let's start at some of the basics. When I think of Tourette syndrome and tics, I think of Tourette syndrome having tics, but maybe not all patients who have tics have Tourette syndrome. And so, I was wondering, A, if you could confirm that's true; and then could you tell us a little bit about some of the diagnostic criteria for each of these conditions? Dr Frey: Sure. So, a tic is a phenomenological description. So basically, what you're seeing is a description of a motor or phonic tic, which is a particular type of movement disorder. Tourette syndrome is a very specific diagnosis, and the diagnostic criteria for Tourette syndrome at this point in time is that you need to have had at least one phonic tic and two or more motor tics over the course of at least a year before the age of eighteen. Dr Albin: Got it. So, there's certainly more specific and a lot more criteria for having Tourette syndrome. I was struck in reading your article how many myths there are surrounding Tourette syndrome and tic disorders kind of in general. What's known about the pathophysiology of Tourette syndrome, and what are some common misconceptions about patients who have this disorder? Dr Frey: Yeah, so I think that's a really excellent question because for so many years, Tourette syndrome and tic disorders in general were thought to be psychogenic in origin, even dating back to when they were first described. The history of Tourette syndrome is quite interesting in that, when Tourette---who, you know, it's named after---was working with Charcot, a lot of the initial descriptors were of actual case reports of patients who had more psychogenic descriptions, and eventually they became known as tic disorders as well. It wasn't until the discovery of Haldol and using Haldol as a treatment for tic disorders that people started to change their perception and say, okay, maybe there is actually a neurologic basis for Tourette syndrome. So, in terms of the pathophysiology, it's not completely known, but what we do know about it, we think that there is some sort of hyperactivity in the corticostriatal-thalamocortical circuits. And we think that because of this hyperactivity, it leads to the hyperactive movement disorder. We think similar circuitry is involved in conditions like OCD, or obsessive compulsive disorder; as well as ADHD, or attention deficit hyperactivity disorder. And because of that, we actually do tend to see an overlap between all three of these conditions in both individuals and families. Dr Albin: And hearing all of that, does this all come back to, sort of, dopamine and, sort of, behavioral motivation, or is it different than that? Dr Frey: It's probably more complex than just dopamine, but there is the thought that dopamine does play a role. And even one of the hypotheses regarding the pathophysiology is actually that these tics might start as habits, and then when the habits become more common, they actually reshape the dopaminergic pathways. And each time a tic occurs, there's a little bit of a dopaminergic reward. And so over time, that reshapes those hyperactive pathways and changes the actual circuitry of the brain, leading it to be not just a habit but part of their neurologic makeup. Dr Albin: It's fascinating to hear how that actually might play into our neural circuitry and, over time, rewire our brain. Fascinating. I mean, this is just so interesting how movement disorders play into such behavioral regulation and some comorbid conditions like ADHD and OCD. I thought it would be really helpful, maybe, to our listeners to kind of think through a case that I suspect is becoming more common. So, if it's okay with you, I'll present sort of a hypothetical. Dr Frey: Absolutely. Dr Albin: This is a father bringing in his seventeen-year-old daughter. She's coming into the clinic because she's been demonstrating, over the past four to six weeks, some jerking movement in her right arm. And it's happened multiple times a day. And it was a pretty sudden onset. She had not had any movement like this before, and then several weeks ago, started moving the right hand. And then it became even more disruptive: her right leg was involved, she had some scrunching her face. This is all happening at a time where she was dealing with some stress, maybe a little bit of applications around college that she was having a lot of anxiety about. How do you sort of approach this case if this is someone who comes to your office? Dr Frey: Sure. So, I think the first thing that you want to get is a good solid history, trying to understand, what is the origin of these abnormal movements and what led to the abnormal movements. Now, a key thing here is that in Tourette syndrome, and most physiologic tic syndromes, there's a pretty early onset. So, in Tourette syndrome, the expected age of onset is between the ages of five and seven years old. So, to have kind of acute new abnormal movements as a seventeen-year-old would be very unusual for a new-onset diagnosis of Tourette syndrome. However, there's a couple of things from the history that could help you. One would be, were there ever tics in the past? Because sometimes, when you think retrospectively, a lot of these patients might have had a simple eye-blinking tic or a coughing tic when they were a child. And perhaps they did have Tourette syndrome, a very mild case of it. But because the tics were never that pronounced, they never went to see anyone about it and it was never known that they had Tourette syndrome in the first place. If there is no history like that and the movements are completely new, out of the blue, of course you want to rule out anything acute that could be going on that could be causing that. Looking at the phenomenology of the movements can also be very helpful. When you're looking at abnormal tic movements, you would expect most cases of something like Tourette syndrome to occur first in the midline and go in a rostrocoidal distribution. So, you mostly see things happening with eye blinking, throat clearing, sniffling, neck snapping. These are some of the immediate tics that start to happen. We also usually start to see simple tics, as opposed to complex tics, at the beginning. Now, over the course of time, many patients do develop more complex tics that might involve the arms or the extremities, but that would be unusual to see this as a presenting feature of new-onset Tourette syndrome. Dr Albin: Got it. So, I'm hearing that the history really matters and that sometimes, like those, like, first-onset seizures, I imagine as a neurointensivist, we see a lot of patients who've had seizures who think that they're presenting the first time. And then we go back and we say, well, actually they have had some abnormal movements at night. Sounds like it's very similar with these movement disorders where you have to really go back and ask, well, was there some sniffling? Did they go through a phase where they were grunting frequently? Because I can imagine that many children make those behaviors, and that it may not have registered as something that was cause for concern. Dr Frey: Absolutely. Dr Albin: And then the other thing I heard from you was that the phenomenology really matters and that there is a typical presentation, starting from sort of the face and working the way down. And that can be really helpful. But in this case, the family is quite clear. No, no, no. She's never had movements like this before. This is- nothing like this. We promise you, did not go through a phase where she was coughing or blinking, or, this is all totally new. And the phenomenology, they say, no, no, she did not start with blinking. It definitely started in the arm and then progressed in its complex movements. So, knowing that about her, how does that sort of shape how you move forward with the diagnosis? Dr Frey: Yeah. So, really good question. And this is something that I think really peaked during the Covid-19 pandemic. We saw an influx of patients, especially teenage girls or young adult girls, who basically would come in and have these new, acute-onset, abnormal movements. We weren't sure what to call them initially. There was some discussion of calling them “explosive tic disorder” and things like that. A lot of these actually looked very similar to psychogenic nonepileptic seizures, where they would come into the emergency department and have many abnormal movements that were so severe, that they were having a “tic attack” and couldn't stop the abnormal movements from occurring. And we saw so many of these cases during the Covid-19 pandemic that it eventually became known as a distinctive diagnostic criteria with the name of “functional ticlike behavior”, or FTLB. When we think about functional ticlike behavior, we think that these tics are driven more by anxiety and stress. A lot of times, the backstory of these patients, they were in a very stressful situation, and that's when the abnormal movement started. So, a very similar kind of backstory to patients that might develop psychogenic nonepileptic seizures. These tics were popularized, for lack of a better term, via social media during the Covid-19 pandemic. One article is out there that even has called these functional ticlike behaviors as “a pandemic within a pandemic”, because there was such a strong showing of ticlike behavior in the clinics during the Covid-19 pandemic. Although social media was thought to play a big role in these functional ticlike behaviors, we think that there's probably a little bit more complexity and nuance to why these functional ticlike behaviors develop. There is probably a little bit of a genetic predisposition. There's probably some other psychosocial factors at play. And when we see cases like this, the best thing that you can do is educate your patients about the differences between functional ticlike behaviors and tics that we see associated with conditions like Tourette syndrome. And then the best types of treatments that we have seen thus far are treating any underlying stressors, if any of those exist, as well as cognitive behavioral therapy has been shown to be somewhat helpful. As the Covid-19 pandemic has wound down, we have actually seen a lot less cases in our clinic. And one reason we think is less stressors, less uncertainty for the future, which we think was a driving precipitant of some of these cases. But it also is not as popularized in the media as well. There were a lot of TikTok users in particular, which lent itself to the name “TikTok tic”. These videos are not as viewed or not as popular as they were during the Covid-19 pandemic. One reason being that because we are not all relegated to our homes, constantly looking to online sources of information---just in general, we have kind of not been on the Internet as much as we were during the Covid-19 pandemic---as a society as a whole. Dr Albin: This is really fascinating how the environmental milieu, for lack of a better word, like, really influenced how patients were experiencing, sort of, functional neurologic disorders. In your article you describe really these three baskets of primary tic---which can then be a part of Tourette syndrome---,functional ticlike behaviors---which really were a unique manifestation of stress and anxiety specifically during the Covid-19 pandemic---, and then tics as a manifestation of some either different underlying etiology or medication side effect. So, when do you get concerned about that secondary etiology? Dr Frey: So secondary tics can occur in a variety of instances. I think some of the more common examples would be in genetic disorders. So, Huntington's disease is a really good example. I think we all associate chorea with Huntington's disease. That's probably the most commonly associated phenomenology that we see with Huntington's disease. But we can see a variety of movement disorders in Huntington's, and one of them is tics. So, when we see tics in association with other types of movement disorders, we should be thinking about a possible genetic etiology. If we see tics in association with other neurologic symptoms, such as seizures or cognitive changes, we should be thinking that this is something besides a primary tic disorder. You also mentioned medication use, and it's really important to think about tardive tics. I know we often think about tardive dyskinesia, and the first kind of phenomenology that jumps into our brain is usually chorea because it's those abnormal lip movements, finger movements, toe movements that we see after a patient has been on, for example, an antipsychotic or an antiemetic that has antidopaminergic properties. However, we can see a variety of abnormal movement disorders that occur secondary to antidopaminergic medications, especially after abrupt withdrawal of these antidopaminergic medications. And tics are one of them. There have been cases reported where people that have tardive tics will still report that they have a premonitory urge, as well as a sense of relief after their tics. So, it actually can seem very similar to Tourette syndrome and the tics that people with Tourette syndrome experience on a regular basis. The key here is that the treatment might differ because if it's due to an antidopaminergic medication or abrupt withdrawal of that antidopaminergic medication, you might need to treat it a little bit differently than you would otherwise. Dr Albin: I love that you bring in, it's not just looking at their specific movement disorder that they may be coming to clinic with, that tic disorder, but are there other movement disorders? Has there been a change in their medication history? Have they had cognitive changes? So really emphasizing the importance of that complete and comprehensive neurologic history, neurologic physical exam, to really get the complete picture so that it's not honing in on, oh, this is a primary tic. That's all there is to it, because it could be so much more. I know we're getting close to sort of the end of our time together, but I really wanted to switch to end on talking about treatment. And your article does such a beautiful job of talking about behavioral interventions and really exciting new medical interventions. But I would like to, if you don't mind, have you focus on, what behavioral counseling and what education do you provide for patients and their families? Because I imagine that the neurologist plays a really important role in educating the patient and their family about these disorders. Dr Frey: Absolutely. When we think about treatment, one of the most important things you can do for patients with Tourette syndrome or other primary tic disorders is educate them. This remains true whether it's a primary tic disorder that we see in Tourette syndrome or the functional ticlike behavior that we've discussed here. A lot of times, because there is such a stigma against people with tic disorders and Tourette syndrome, when they hear that they have Tourette syndrome or they are diagnosed with that, sometimes that can be an upsetting diagnosis. And sometimes you have to take time explaining what exactly that means and debunking a lot of the myths that go along with the stigmas associated with Tourette syndrome. I think a lot of times people are under the false assumption that people with Tourette syndrome cannot lead normal lives and cannot hold down jobs and cannot be productive members of society. None of that is true. Most of my patients have great lives, good quality of life, and are able to go about their day-to-day life without any major issues. And one of the reasons for that is we do have a lot of great treatment options available. Another important stigma to break down is that people with tic disorders are doing this for attention or doing this because they are trying to get something from someone else. That is absolutely false. We do think that the tics themselves are semivolitional because people with Tourette syndrome have some degree of control over their tics. They can suppress them for a period of time. But a lot of people with tic disorders and Tourette syndrome will describe their tics as if you're trying to hold onto a sneeze. And you can imagine how uncomfortable it is to hold in a sneeze. We're all able to do it for a period of time, but it's much easier to just allow that sneeze to occur. And a lot of times that's what they are experiencing, too. So, although there is some degree of control, it's not complete control, and they're certainly not doing these tics on purpose or for attention. So that's another important myth to debunk when you're counseling patients and their families. I think the dynamic between young patients that are presenting with their parents or guardians, sometimes that dynamic is a little bit challenging because another faulty assumption is that parents feel they are responsible for having this happen to their child. There used to be a really strong sense that parents were responsible for the tics that occurred in their children, and that is also absolutely not true. Parenting has nothing to do with having the tics or not. We know that this is a neurodevelopmental disorder. The brain is indeed wired differently and it's important to counsel that with the parents, too, so that they understand what tools they need to be successful for their children as well. Dr Albin: I love that. So, it's a lot of partnership with patients and their families. I really like that this is just a wire different, and I hope over time that working together we as neurologists can help break down some of that stigmatization for these patients. This has been an absolutely phenomenal discussion. I have so enjoyed learning from your article. For the listeners out there, there are some really phenomenal tables that go into sort of how to approach this from the office perspective, how to approach it from the treatment perspective. So, thank you again, Dr Jessica Frey, for your article on Tourette syndrome and tic disorders, which appears in the August 2025 Continuum issue on movement disorders. Be sure to check out Continuum Audio episodes from this and other issues, and thank you so much to our listeners for joining us today. Dr Frey: Thank you for having me. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Dean's Chat hosts, Drs. Jensen and Richey welcome Dr. Brian Derner to the podcast! Brian Derner, DPM, is a board-certified podiatric surgeon with Kaiser Permanente San Leandro, specializing in advanced foot and ankle surgery—including total ankle replacement, flatfoot reconstruction, Charcot deformity corrections, and Lapiplasty bunion repair.  He completed his podiatric medical training (DPM) and a three-year surgical residency at Kaiser Permanente Northern California, followed by a reconstructive foot and ankle fellowship at The CORE Institute, further honing his expertise in complex reconstructive procedures.  Beyond his surgical practice, Dr. Derner volunteers with Bones Pro Bono, delivering pro bono foot and ankle surgeries to underserved communities in Vietnam and Kenya. Join us for a fabulous discussion with a young leader in podiatric medicine and surgery!

Auditrices : - Après avoir perdu son mari à cause de la maladie de Charcot, Nathalie milite pour la fin de vie. - Émilie témoigne du harcèlement que subi son fils  sur les réseaux sociaux. - Atteint d'un cancer, Jeanine revient sur la fin de vie choisie par son père. Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Auditrices : - Après avoir perdu son mari à cause de la maladie de Charcot, Nathalie milite pour la fin de vie. - Émilie témoigne du harcèlement que subi son fils  sur les réseaux sociaux. - Atteint d'un cancer, Jeanine revient sur la fin de vie choisie par son père. Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Auditrices : - Après avoir perdu son mari à cause de la maladie de Charcot, Nathalie milite pour la fin de vie. - Émilie témoigne du harcèlement que subi son fils  sur les réseaux sociaux. - Atteint d'un cancer, Jeanine revient sur la fin de vie choisie par son père. Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

C'est dans la nuit du 15 au 16 juillet 1893 que meurt celui qui, inlassablement, des années durant, aura tenté de comprendre les troubles du comportement de certains de ses semblables : Jean-Martin Charcot. Grand médecin de l'hôpital de la Salpêtrière, à Paris, il occupera, en 1882, la première chaire de neurologie et explorera les continents, alors mal connus, de l'hystérie et de l'hypnose. Freud, qui fut son élève, ne cachera pas l'influence qu'eut le maître sur son travail. Charcot demeure également un lien entre la science et l'art. Ses dessins, d'une grande habilité et d'une profonde sensibilité, révèlent une connaissance profonde de l'humain, un diagnostic précis des anomalies anatomiques. Ils nous disent le lien étroit qui unit l'image du corps et la psychiatrie. La curiosité du savant, son regard aigu sur ses contemporains et son talent artistiques auront permis une avancée spectaculaire de la science. Avec Catherine Bouchara, "Charcot, une vie avec l'image", Editions Philippe Rey - Sujets traités : Jean-Martin Charcot, médecin, Salpêtrière, hystérie, hypnose, psychiatrie, science Merci pour votre écoute Un Jour dans l'Histoire, c'est également en direct tous les jours de la semaine de 13h15 à 14h30 sur www.rtbf.be/lapremiere Retrouvez tous les épisodes d'Un Jour dans l'Histoire sur notre plateforme Auvio.be :https://auvio.rtbf.be/emission/5936 Intéressés par l'histoire ? Vous pourriez également aimer nos autres podcasts : L'Histoire Continue: https://audmns.com/kSbpELwL'heure H : https://audmns.com/YagLLiKEt sa version à écouter en famille : La Mini Heure H https://audmns.com/YagLLiKAinsi que nos séries historiques :Chili, le Pays de mes Histoires : https://audmns.com/XHbnevhD-Day : https://audmns.com/JWRdPYIJoséphine Baker : https://audmns.com/wCfhoEwLa folle histoire de l'aviation : https://audmns.com/xAWjyWCLes Jeux Olympiques, l'étonnant miroir de notre Histoire : https://audmns.com/ZEIihzZMarguerite, la Voix d'une Résistante : https://audmns.com/zFDehnENapoléon, le crépuscule de l'Aigle : https://audmns.com/DcdnIUnUn Jour dans le Sport : https://audmns.com/xXlkHMHSous le sable des Pyramides : https://audmns.com/rXfVppvN'oubliez pas de vous y abonner pour ne rien manquer.Et si vous avez apprécié ce podcast, n'hésitez pas à nous donner des étoiles ou des commentaires, cela nous aide à le faire connaître plus largement. Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Drs. Jensen and Richey welcome Dr. Hoa Phan to Dean's Chat!  Today we are going to discuss fellowships, residency, the residency match, and the MP2 (the 2nd round match for those not matching the first round. This episode is sponsored by Bako Diagnostics! Dr. Phan graduated with a Bachelor of Science in Biochemistry from Temple University and subsequently earned his Doctor of Podiatric Medicine Degree from the Temple University School of Podiatric Medicine. ​ He completed his residency training at Cape Fear Valley Medical Center in Fayetteville North Carolina and was a member of the inaugural class.  He is currently a UT Health San Antonio Amputation Prevention and Research Fellow. His professional interest includes revisional foot and ankle surgery, utilization of external fixation, orthoplastic reconstruction and Charcot foot and ankle management.   Enjoy the discussion - pertinent for students, residents, and potential fellows!

Ecoutez Le 2ème œil de Philippe Caverivière du 27 juin 2025.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Listener Appreciation Week Day 4 Renowned French explorer Jean-Baptiste Charcot explored the polar regions for many years aboard his ship, the Pourquoi Pas. When fellow explorer Roald Amundsen's plane went missing in 1928, Charcot joined the search for the Norwegian. Amundsen himself was searching for the crashed Italian airship, Italia, and its captain Umberto Nobile. As a thank you to all Shipwreck and Sea Dogs listeners, I am bringing you a bonus mini-episode each day this week. As another bonus, all merchandise is 25% OFF during Listener Appreciation Week! Go to ⁠⁠⁠shop.shipwrecksandseadogs.com⁠⁠⁠ and use code LISTENER2025 at check out. Please share this episode with a friend, family member, or coworker, and help Shipwrecks and Sea Dogs reach a larger audience. ⁠⁠https://www.shipwrecksandseadogs.com/⁠⁠ Written, edited, and produced by Rich Napolitano. Original theme music for Shipwrecks and Sea Dogs by ⁠⁠⁠⁠⁠Sean Sigfried⁠⁠⁠⁠⁠. Go AD-FREE by becoming a Patreon Officer's Club Member! Join at ⁠⁠⁠⁠⁠https://www.patreon.com/shipwreckspod⁠⁠ Join the Into History Network for ad-free access to this and many other fantastic history podcasts! ⁠⁠⁠⁠⁠https://www.intohistory.com/shipwreckspod⁠⁠⁠⁠⁠ You can support the podcast with a donation of any amount at: ⁠⁠⁠⁠⁠https://www.buymeacoffee.com/shipwreckspod⁠⁠⁠⁠⁠ Follow Shipwrecks and Sea Dogs ⁠⁠⁠⁠⁠Subscribe on YouTube⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Follow on BlueSky⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Follow on Threads⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Follow on Instagram⁠⁠⁠⁠⁠ ⁠F⁠⁠⁠⁠ollow on Facebook⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In the conclusion of this series on Charcot, guest host Eitan Ingall discusses treatment strategies with Drs. Carroll Jones, Kaitlin Neary, and Matt Conti. For additional educational resources, visit AOFAS.org

[GRAINE DE METAMORPHOSE] Xavier Pitois reçoit Lorène Vivier, 37 ans, atteinte de Sclérose Latérale Amyotrophique (SLA) ou maladie de Charcot. Comment continue-t-on à avancer quand le corps lâche ? Que fait-on du temps, quand l'avenir se rétrécit ? Et comment transforme-t-on un diagnostic bouleversant en énergie d'action, pour soi, mais aussi pour les autres ? Lorène Vivier a choisi de faire de son quotidien un engagement : sensibiliser, témoigner, mobiliser. Une réflexion profonde sur le sens de la vie. Épisode #127Quelques citations du podcast avec Lorène Vivier :"On est en 2925, on va sur Mars, on ne peut toujours pas aller investiguer le système neurologique du corps humain.""Je n'ai plus envie de ramener du chiffre d'affaires, j'ai envie de ramener de l'argent pour la recherche, pour moi c'est ça le plus important.""C'est important de vivre pleinement les choses aujourd'hui."Thèmes abordés lors du podcast avec Lorène Vivier :00:00 Introduction03:22 Les origines du livre de Lorène Vivier06:47 L'importance de parler de la SLA07:16 Qu'est-ce que la maladie de Charcot ou SLA ?09:02 L'annonce de la maladie14:20 Les phrases qui apaisent16:38 La phase de lutte19:38 Le sens de l'engagement associatif22:04 Recherche et moyens financiers23:16 L'importance d'impliquer les entreprises25:10 Le goût du voyage26:27 La spiritualité : un vrai soutien30:05 Maladie progressive et sens de la vie32:14 Les aménagements au quotidien33:44 Comment aider ?34:51 Le regard des autres36:39 Le rapport au corps38:52 Les deux experts indispensables39:20 La place des aidants et de la famille41:28 Mettre en lumière la maladieAvant-propos et précautions à l'écoute du podcast Découvrez Objectif Métamorphose, notre programme en 12 étapes pour partir à la rencontre de soi-même.Recevez chaque semaine l'inspirante newsletter Métamorphose par Anne GhesquièreFaites le TEST gratuit de La Roue Métamorphose avec 9 piliers de votre vie !Suivez nos RS : Insta, Facebook & TikTokAbonnez-vous sur Apple Podcast / Spotify / Deezer / CastBox/ YoutubeSoutenez Métamorphose en rejoignant la Tribu MétamorphosePhoto © Christophe Martin Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Join guest host Eitan Ingall as he discusses the challenges and strategies of treating Charcot with Drs. Carroll Jones, Kaitlin Neary, and Matt Conti in part 1 of this 2 part series. For additional educational resources, visit AOFAS.org

Dean's Chat hosts, Drs. Jensen and Richey, welcome Dr. Narenda Patel to the podcast! Narendra Patel, DPM is a highly skilled podiatric foot and ankle surgeon based in the Northwest Suburbs of Chicago, Illinois. He is a partner surgeon at Barrington Orthopedic Specialists. He is known for his expertise in diagnosing and treating a wide range of foot and ankle conditions, including sports injuries, fractures, peripheral nerve injuries, ankle replacement, and Charcot and Trauma expert. Dr. Patel earned his Doctor of Podiatric Medicine degree from the New York College of Podiatric Medicine in New York City and completed a comprehensive three-year post-doctoral surgery residency. He has been in practice since 1997. Dr. Patel is Faculty Attending Surgeon for the Ascension St. Joseph's Surgical Residency Program and Fellowship Trainer for the Complex Deformity Correction & Microsurgical Limb Reconstruction at Ascension St. Joseph. Dr. Patel has built a reputation for providing compassionate and personalized care to his patients. He is committed to staying up to date with the latest advances in foot and ankle surgery and uses state-of-the-art techniques and equipment to ensure the best possible outcomes for his patients. Dr. Narendra R. Patel, DPM is a skilled and compassionate podiatric foot and ankle surgeon who is dedicated to providing the highest level of care to his patients. With his expertise and commitment to excellence, he has become one of the most trusted foot and ankle surgeons in the Northwest Suburbs of Chicago, Illinois. When he's not seeing patients, Dr. Patel enjoys photography, traveling abroad, and electronic dance music. Dr. Patel enjoys going on humanitarian mission trips. https://bakodx.com/ https://bmef.org/ www.explorepodmed.org https://podiatrist2be.com/  

All the logical answers to Charcot's escape and disappearances had come up... but why should an escaped convict be logical? Solitary by Robert Silverberg. That's next on The Lost Sci-Fi Podcast.Thanks to Phee808 for another 5 star review on Apple Podcast, “The perfect narration to a treasure trove of incredible talent. They don't make them like this anymore but fortunately we can still hear them. The narration is on point and passionate and matches the mood of the stories perfectly.” Thanks Phee808!If you are a fan of Robert Silverberg, as I am, you will be happy with today's episode which was the cover story in Future Science Fiction number 32 in Spring 1957. Open this 35 cent magazine to page 4, Solitary by Robert Silverberg…Next on The Lost Sci-Fi Podcast, What happens when a secret society demands your fortune—or sacrifices innocent lives instead? An electrifying tale of power, greed, and morality that will keep you in suspense until the very end. The Minions of Midas by Jack London.☕ Buy Me a Coffee https://www.buymeacoffee.com/scottsV===========================

Two Short stories from the 1800s. The Tell-Tale Heart and The Masque of the Red Death by Edgar Allan Poe. That's next on The Lost Sci-Fi Podcast.Did you know we take requests? We do, and both of the stories you are about to hear have been requested a number of times. If there is a vintage science fiction story you'd like to hear send us an email, scott@lostscifi.com. He was born Edgar Poe in Boston in 1809, orphaned at the age of 2 and taken in by a wealthy merchant, John Allan and his wife, Francis. And that's how he came to be known as Edgar Allan Poe. John Allan did not adopt Poe and that's why he didn't take Allan as his last name. Let's travel back in time 182 years to January 1843. Our story was first published in The Pioneer, The Tell-Tale Heart by Edgar Allan Poe…Up next, a story published 9 months earlier, in Graham's Magazine in April 1842, The Masque of the Red Death by Edgar Allan Poe...Next on The Lost Sci-Fi Podcast, All the logical answers to Charcot's escape and disappearances had come up... but why should an escaped convict be logical? Solitary by Robert Silverberg.☕ Buy Me a Coffee https://www.buymeacoffee.com/scottsV===========================

Today's guest is Emily Capley, who has an amazing success story reversing very serious health issues and getting back to a normal life, even with type 1 diabetes. See her bio below and enjoy the video! Emily's bio: I am a 43-year-old woman who has type 1 diabetes. After following the ADA guidelines for 29 years i now have numerous long-term complications. Kidney failure, retinopathy, neuropathy that led to Charcot foot disease, frozen shoulder in both arms to name a few. Using a ketogenic diet starting in August 2020 I was able to better control my diabetes with much less insulin. I've been strict carnivore since January 2024 and my complications are now slowly reversing and my last A1C was 5.4. My body is healing eating only meat/animal products.   ✅ Dr Chaffee's website: www.thecarnivorelife.com ✅Join my PATREON for early releases, bonus content, and weekly Zoom meetings! https://www.patreon.com/AnthonyChaffeeMD ✅Sign up for our 30-day carnivore challenge and group here! https://www.howtocarnivore.com/ ✅Stockman Steaks, Australia Discount link for home delivered frozen grass-fed and grass finished pasture raised meat locally sourced here in Australia! Use discount code "CHAFFEE" for free gift with qualifying orders! http://www.stockmansteaks.com.au/chaffee ✅ 60-minute consultation with Dr Chaffee https://calendly.com/anthonychaffeemd/60-minute-consultation   Sponsors and Affiliates: ✅ Brand Ambassador for Stone and Spear tallow and soaps referral link https://www.stoneandspeartallow.com/?ref=gx0gql8b Discount Code "CHAFFEE" for 10% off ✅ Carnivore t-shirts from the Plant Free MD  www.plantfreetees.com ✅THE CARNIVORE BAR: Discount Code "Anthony" for 10% off all orders!   https://the-carnivore-bar.myshopify.com/?sca_ref=1743809.v3IrTuyDIi ✅Schwank Grill (Natural Gas or Propane) https://glnk.io/503n/anthonychaffeemd $150 OFF with Discount Code: ANTHONYMD ✅X3 bar system with discount code "DRCHAFFEE" https://www.kqzyfj.com/click-100676052-13511487 ✅Cerule Stem cells https://DrChaffee.cerule.com ✅CARNIVORE CRISPS: Discount Code "DRCHAFFEEMD" for 10% off all orders! www.carnivorecrisps.com ✅Shop Amazon https://www.amazon.com/shop/anthonychaffeemd?ref=ac_inf_hm_vp   And please like and subscribe to my podcast here and Apple/Google podcasts, as well as my YouTube Channel to get updates on all new content, and please consider giving a 5-star rating as it really helps!   This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Music Credit: Music by: bensound.com License code: MPTEUCI8DAXJOKPZ Music: bensound.com License code: FJQPPMCJLHEOYGQB Music: Bensound.com/royalty-free-music License code: KQAKMWSXIH3MJ4WX Music I use: https://www.bensound.com License code: 58NN4QOSKWJ7ASX9